0001435064 false --09-30 Q2 P3Y P7Y P15Y 0001435064 2021-10-01 2022-03-31 0001435064 us-gaap:CommonStockMember 2021-10-01 2022-03-31 0001435064 CETX:Series1PreferredStockMember 2021-10-01 2022-03-31 0001435064 2022-05-13 0001435064 2022-03-31 0001435064 2021-09-30 0001435064 CETX:Series1PreferredStockMember 2022-03-31 0001435064 CETX:Series1PreferredStockMember 2021-09-30 0001435064 us-gaap:SeriesCPreferredStockMember 2022-03-31 0001435064 us-gaap:SeriesCPreferredStockMember 2021-09-30 0001435064 CETX:SeriesOnePreferredStockMember 2022-03-31 0001435064 CETX:SeriesOnePreferredStockMember 2021-09-30 0001435064 2022-01-01 2022-03-31 0001435064 2021-01-01 2021-03-31 0001435064 2020-10-01 2021-03-31 0001435064 us-gaap:PreferredStockMember CETX:Series1PreferredStockMember 2021-09-30 0001435064 us-gaap:PreferredStockMember us-gaap:SeriesAPreferredStockMember 2021-09-30 0001435064 us-gaap:PreferredStockMember us-gaap:SeriesCPreferredStockMember 2021-09-30 0001435064 us-gaap:CommonStockMember 2021-09-30 0001435064 us-gaap:AdditionalPaidInCapitalMember 2021-09-30 0001435064 us-gaap:RetainedEarningsMember 2021-09-30 0001435064 us-gaap:TreasuryStockMember 2021-09-30 0001435064 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-09-30 0001435064 us-gaap:NoncontrollingInterestMember 2021-09-30 0001435064 us-gaap:PreferredStockMember CETX:Series1PreferredStockMember 2021-12-31 0001435064 us-gaap:PreferredStockMember us-gaap:SeriesAPreferredStockMember 2021-12-31 0001435064 us-gaap:PreferredStockMember us-gaap:SeriesCPreferredStockMember 2021-12-31 0001435064 us-gaap:CommonStockMember 2021-12-31 0001435064 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001435064 us-gaap:RetainedEarningsMember 2021-12-31 0001435064 us-gaap:TreasuryStockMember 2021-12-31 0001435064 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-12-31 0001435064 2021-12-31 0001435064 us-gaap:NoncontrollingInterestMember 2021-12-31 0001435064 us-gaap:PreferredStockMember CETX:Series1PreferredStockMember 2020-09-30 0001435064 us-gaap:PreferredStockMember us-gaap:SeriesAPreferredStockMember 2020-09-30 0001435064 us-gaap:PreferredStockMember us-gaap:SeriesCPreferredStockMember 2020-09-30 0001435064 us-gaap:CommonStockMember 2020-09-30 0001435064 us-gaap:AdditionalPaidInCapitalMember 2020-09-30 0001435064 us-gaap:RetainedEarningsMember 2020-09-30 0001435064 us-gaap:TreasuryStockMember 2020-09-30 0001435064 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-09-30 0001435064 2020-09-30 0001435064 us-gaap:NoncontrollingInterestMember 2020-09-30 0001435064 us-gaap:PreferredStockMember CETX:Series1PreferredStockMember 2020-12-31 0001435064 us-gaap:PreferredStockMember us-gaap:SeriesAPreferredStockMember 2020-12-31 0001435064 us-gaap:PreferredStockMember us-gaap:SeriesCPreferredStockMember 2020-12-31 0001435064 us-gaap:CommonStockMember 2020-12-31 0001435064 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0001435064 us-gaap:RetainedEarningsMember 2020-12-31 0001435064 us-gaap:TreasuryStockMember 2020-12-31 0001435064 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-12-31 0001435064 2020-12-31 0001435064 us-gaap:NoncontrollingInterestMember 2020-12-31 0001435064 us-gaap:PreferredStockMember CETX:Series1PreferredStockMember 2021-10-01 2021-12-31 0001435064 us-gaap:PreferredStockMember us-gaap:SeriesAPreferredStockMember 2021-10-01 2021-12-31 0001435064 us-gaap:PreferredStockMember us-gaap:SeriesCPreferredStockMember 2021-10-01 2021-12-31 0001435064 us-gaap:CommonStockMember 2021-10-01 2021-12-31 0001435064 us-gaap:AdditionalPaidInCapitalMember 2021-10-01 2021-12-31 0001435064 us-gaap:RetainedEarningsMember 2021-10-01 2021-12-31 0001435064 us-gaap:TreasuryStockMember 2021-10-01 2021-12-31 0001435064 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-10-01 2021-12-31 0001435064 2021-10-01 2021-12-31 0001435064 us-gaap:NoncontrollingInterestMember 2021-10-01 2021-12-31 0001435064 us-gaap:PreferredStockMember CETX:Series1PreferredStockMember 2022-01-01 2022-03-31 0001435064 us-gaap:PreferredStockMember us-gaap:SeriesAPreferredStockMember 2022-01-01 2022-03-31 0001435064 us-gaap:PreferredStockMember us-gaap:SeriesCPreferredStockMember 2022-01-01 2022-03-31 0001435064 us-gaap:CommonStockMember 2022-01-01 2022-03-31 0001435064 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-03-31 0001435064 us-gaap:RetainedEarningsMember 2022-01-01 2022-03-31 0001435064 us-gaap:TreasuryStockMember 2022-01-01 2022-03-31 0001435064 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-01-01 2022-03-31 0001435064 us-gaap:NoncontrollingInterestMember 2022-01-01 2022-03-31 0001435064 us-gaap:PreferredStockMember CETX:Series1PreferredStockMember 2020-10-01 2020-12-31 0001435064 us-gaap:PreferredStockMember us-gaap:SeriesAPreferredStockMember 2020-10-01 2020-12-31 0001435064 us-gaap:PreferredStockMember us-gaap:SeriesCPreferredStockMember 2020-10-01 2020-12-31 0001435064 us-gaap:CommonStockMember 2020-10-01 2020-12-31 0001435064 us-gaap:AdditionalPaidInCapitalMember 2020-10-01 2020-12-31 0001435064 us-gaap:RetainedEarningsMember 2020-10-01 2020-12-31 0001435064 us-gaap:TreasuryStockMember 2020-10-01 2020-12-31 0001435064 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-10-01 2020-12-31 0001435064 2020-10-01 2020-12-31 0001435064 us-gaap:NoncontrollingInterestMember 2020-10-01 2020-12-31 0001435064 us-gaap:PreferredStockMember CETX:Series1PreferredStockMember 2021-01-01 2021-03-31 0001435064 us-gaap:PreferredStockMember us-gaap:SeriesAPreferredStockMember 2021-01-01 2021-03-31 0001435064 us-gaap:PreferredStockMember us-gaap:SeriesCPreferredStockMember 2021-01-01 2021-03-31 0001435064 us-gaap:CommonStockMember 2021-01-01 2021-03-31 0001435064 us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-03-31 0001435064 us-gaap:RetainedEarningsMember 2021-01-01 2021-03-31 0001435064 us-gaap:TreasuryStockMember 2021-01-01 2021-03-31 0001435064 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-01-01 2021-03-31 0001435064 us-gaap:NoncontrollingInterestMember 2021-01-01 2021-03-31 0001435064 us-gaap:PreferredStockMember CETX:Series1PreferredStockMember 2022-03-31 0001435064 us-gaap:PreferredStockMember us-gaap:SeriesAPreferredStockMember 2022-03-31 0001435064 us-gaap:PreferredStockMember us-gaap:SeriesCPreferredStockMember 2022-03-31 0001435064 us-gaap:CommonStockMember 2022-03-31 0001435064 us-gaap:AdditionalPaidInCapitalMember 2022-03-31 0001435064 us-gaap:RetainedEarningsMember 2022-03-31 0001435064 us-gaap:TreasuryStockMember 2022-03-31 0001435064 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-03-31 0001435064 us-gaap:NoncontrollingInterestMember 2022-03-31 0001435064 us-gaap:PreferredStockMember CETX:Series1PreferredStockMember 2021-03-31 0001435064 us-gaap:PreferredStockMember us-gaap:SeriesAPreferredStockMember 2021-03-31 0001435064 us-gaap:PreferredStockMember us-gaap:SeriesCPreferredStockMember 2021-03-31 0001435064 us-gaap:CommonStockMember 2021-03-31 0001435064 us-gaap:AdditionalPaidInCapitalMember 2021-03-31 0001435064 us-gaap:RetainedEarningsMember 2021-03-31 0001435064 us-gaap:TreasuryStockMember 2021-03-31 0001435064 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-03-31 0001435064 2021-03-31 0001435064 us-gaap:NoncontrollingInterestMember 2021-03-31 0001435064 CETX:VirtualDriverInteractiveMember 2020-10-25 2020-10-26 0001435064 CETX:VirtualDriverInteractiveMember 2020-10-26 0001435064 CETX:InstallmentOneMember 2021-10-25 2021-10-26 0001435064 CETX:InstallmentTwoMember 2022-10-25 2022-10-26 0001435064 2021-05-31 0001435064 CETX:VirtualDriverInteractiveMember CETX:ProprietarySoftwareMember 2020-10-25 2020-10-26 0001435064 CETX:VirtualDriverInteractiveMember CETX:InventoryMember 2020-10-25 2020-10-26 0001435064 CETX:VirtualDriverInteractiveMember us-gaap:GoodwillMember 2020-10-25 2020-10-26 0001435064 CETX:MasterpieceVRMember 2020-11-13 0001435064 CETX:MasterpieceVRMember 2022-01-19 0001435064 us-gaap:WarrantMember 2022-01-01 2022-03-31 0001435064 us-gaap:WarrantMember 2021-01-01 2021-03-31 0001435064 us-gaap:WarrantMember 2021-10-01 2022-03-31 0001435064 us-gaap:WarrantMember 2020-10-01 2021-03-31 0001435064 us-gaap:EmployeeStockOptionMember 2022-01-01 2022-03-31 0001435064 us-gaap:EmployeeStockOptionMember 2021-01-01 2021-03-31 0001435064 us-gaap:EmployeeStockOptionMember 2021-10-01 2022-03-31 0001435064 us-gaap:EmployeeStockOptionMember 2020-10-01 2021-03-31 0001435064 CETX:AdvancedTechnologiesMember 2022-01-01 2022-03-31 0001435064 CETX:AdvancedTechnologiesMember 2021-01-01 2021-03-31 0001435064 CETX:AdvancedTechnologiesMember 2021-10-01 2022-03-31 0001435064 CETX:AdvancedTechnologiesMember 2020-10-01 2021-03-31 0001435064 CETX:IndustrialServicesMember 2022-01-01 2022-03-31 0001435064 CETX:IndustrialServicesMember 2021-01-01 2021-03-31 0001435064 CETX:IndustrialServicesMember 2021-10-01 2022-03-31 0001435064 CETX:IndustrialServicesMember 2020-10-01 2021-03-31 0001435064 CETX:AdvancedTechnologiesMember 2022-03-31 0001435064 CETX:AdvancedTechnologiesMember 2021-09-30 0001435064 CETX:IndustrialServicesMember 2022-03-31 0001435064 CETX:IndustrialServicesMember 2021-09-30 0001435064 us-gaap:FairValueInputsLevel1Member CETX:MarketableSecuritiesMember 2022-03-31 0001435064 us-gaap:FairValueInputsLevel2Member CETX:MarketableSecuritiesMember 2022-03-31 0001435064 us-gaap:FairValueInputsLevel3Member CETX:MarketableSecuritiesMember 2022-03-31 0001435064 CETX:MarketableSecuritiesMember 2022-03-31 0001435064 us-gaap:FairValueInputsLevel1Member 2022-03-31 0001435064 us-gaap:FairValueInputsLevel2Member 2022-03-31 0001435064 us-gaap:FairValueInputsLevel3Member 2022-03-31 0001435064 us-gaap:FairValueInputsLevel1Member CETX:MarketableSecuritiesMember 2021-09-30 0001435064 us-gaap:FairValueInputsLevel2Member CETX:MarketableSecuritiesMember 2021-09-30 0001435064 us-gaap:FairValueInputsLevel3Member CETX:MarketableSecuritiesMember 2021-09-30 0001435064 CETX:MarketableSecuritiesMember 2021-09-30 0001435064 us-gaap:FairValueInputsLevel1Member 2021-09-30 0001435064 us-gaap:FairValueInputsLevel2Member 2021-09-30 0001435064 us-gaap:FairValueInputsLevel3Member 2021-09-30 0001435064 us-gaap:LandMember 2022-03-31 0001435064 us-gaap:LandMember 2021-09-30 0001435064 CETX:BuildingAndLeaseholdImprovementsMember 2022-03-31 0001435064 CETX:BuildingAndLeaseholdImprovementsMember 2021-09-30 0001435064 us-gaap:FurnitureAndFixturesMember 2022-03-31 0001435064 us-gaap:FurnitureAndFixturesMember 2021-09-30 0001435064 CETX:ComputersAndSoftwareMember 2022-03-31 0001435064 CETX:ComputersAndSoftwareMember 2021-09-30 0001435064 us-gaap:MachineryAndEquipmentMember 2022-03-31 0001435064 us-gaap:MachineryAndEquipmentMember 2021-09-30 0001435064 srt:MinimumMember 2022-03-31 0001435064 srt:MaximumMember 2022-03-31 0001435064 CETX:MasterpieceVRMember 2022-03-31 0001435064 CETX:MasterpieceVRMember 2021-09-30 0001435064 CETX:AssetPurchaseAgreementMember CETX:GriffinFiltersLLCMember CETX:DuconTechnologiesIncMember CETX:AronGovilMember 2019-08-30 2019-08-31 0001435064 CETX:DuconTechnologiesIncMember 2022-03-31 0001435064 CETX:DuconTechnologiesIncMember 2021-09-30 0001435064 CETX:GriffinFiltersLLCMember 2021-10-01 2022-03-31 0001435064 us-gaap:DisputesMember CETX:IncorrectlyHandledAndAccountedMember 2021-02-22 2021-02-23 0001435064 us-gaap:DisputesMember CETX:IncorrectlyHandledAndAccountedMember 2016-10-01 2017-09-30 0001435064 us-gaap:DisputesMember CETX:IncorrectlyHandledAndAccountedMember 2017-10-01 2018-09-30 0001435064 CETX:IncorrectlyHandledAndAccountedMember 2017-10-01 2018-09-30 0001435064 CETX:IncorrectlyHandledAndAccountedMember 2018-09-30 0001435064 CETX:AronGovilMember CETX:SettlementAgreementMember 2021-02-26 0001435064 CETX:AronGovilMember us-gaap:SeriesAPreferredStockMember CETX:SettlementAgreementMember 2021-03-27 2021-03-31 0001435064 CETX:AronGovilMember us-gaap:SeriesCPreferredStockMember CETX:SettlementAgreementMember 2021-03-27 2021-03-31 0001435064 CETX:AronGovilMember CETX:SeriesOnePreferredStockMember CETX:SettlementAgreementMember 2021-03-27 2021-03-31 0001435064 CETX:AronGovilMember CETX:SettlementAgreementMember 2021-01-01 2021-03-31 0001435064 CETX:AronGovilMember CETX:SettlementAgreementMember CETX:SecuredPromissoryNoteMember 2021-03-31 0001435064 CETX:AronGovilMember CETX:SettlementAgreementMember CETX:SecuredPromissoryNoteMember 2021-03-27 2021-03-31 0001435064 CETX:FultonBankMember 2015-12-15 0001435064 CETX:FultonBankMember us-gaap:LondonInterbankOfferedRateLIBORMember 2015-12-15 0001435064 CETX:FultonBankMember us-gaap:LondonInterbankOfferedRateLIBORMember 2022-03-31 0001435064 CETX:FultonBankMember us-gaap:LondonInterbankOfferedRateLIBORMember 2021-09-30 0001435064 CETX:FultonBankMember 2022-03-31 0001435064 CETX:FultonBankMember 2021-09-30 0001435064 CETX:AdvancedIndustrialServicesIncMember 2015-12-13 2015-12-15 0001435064 CETX:AdvancedIndustrialServicesIncMember us-gaap:LondonInterbankOfferedRateLIBORMember 2015-12-13 2015-12-15 0001435064 CETX:AdvancedIndustrialServicesIncMember 2022-03-31 0001435064 CETX:AdvancedIndustrialServicesIncMember 2021-09-30 0001435064 CETX:NewAdvancedIndustrialServicesIncMember CETX:FultonBankMember 2018-05-01 2018-05-01 0001435064 CETX:NewAdvancedIndustrialServicesIncMember us-gaap:LondonInterbankOfferedRateLIBORMember 2018-05-01 2018-05-01 0001435064 CETX:NewAdvancedIndustrialServicesIncMember 2022-03-31 0001435064 CETX:NewAdvancedIndustrialServicesIncMember CETX:FultonBankMember 2021-09-30 0001435064 CETX:NewAdvancedIndustrialServicesIncMember CETX:FultonBankMember 2022-03-31 0001435064 CETX:NotesPayableDueOnMayOneTwoThousandTwentyThreeOneMember CETX:FultonBankMember 2020-01-28 0001435064 CETX:NotesPayableDueOnMayOneTwoThousandTwentyThreeOneMember us-gaap:LondonInterbankOfferedRateLIBORMember CETX:FultonBankMember 2020-01-27 2020-01-28 0001435064 CETX:NotesPayableDueOnMayOneTwoThousandTwentyThreeOneMember CETX:FultonBankMember 2022-03-31 0001435064 CETX:NotesPayableDueOnMayOneTwoThousandTwentyThreeOneMember CETX:FultonBankMember 2021-09-30 0001435064 CETX:FultonBankMember CETX:NotesPayableDueOnMayOneTwoThousandTwentyThreeOneMember 2020-01-27 2020-01-28 0001435064 CETX:IndependentThirdPartyMember CETX:NotesPayableMember 2020-09-30 0001435064 CETX:IndependentThirdPartyMember 2020-09-30 0001435064 CETX:IndependentThirdPartyMember 2020-09-27 2020-09-30 0001435064 CETX:IndependentThirdPartyMember 2022-03-31 0001435064 CETX:IndependentThirdPartyMember 2021-09-30 0001435064 CETX:NotesPayableMember CETX:IndependentThirdPartyTwoMember 2021-09-30 0001435064 CETX:IndependentThirdPartyTwoMember 2021-09-30 0001435064 CETX:IndependentThirdPartyTwoMember 2021-09-27 2021-09-30 0001435064 CETX:IndependentThirdPartyTwoMember 2022-03-31 0001435064 CETX:NotesPayableMember CETX:IndependentThirdPartyThreeMember 2022-02-22 0001435064 CETX:IndependentThirdPartyThreeMember 2022-02-22 0001435064 CETX:IndependentThirdPartyThreeMember 2022-02-21 2022-02-22 0001435064 CETX:IndependentThirdPartyTwoMember 2022-02-22 0001435064 CETX:IndependentThirdPartyTwoMember 2022-02-21 2022-02-22 0001435064 CETX:IndependentThirdPartyThreeMember 2022-03-31 0001435064 CETX:TermLoanAgreementMember 2022-03-30 0001435064 CETX:TermLoanAgreementMember 2022-03-30 2022-03-30 0001435064 CETX:TermLoanAgreementMember 2022-03-31 0001435064 CETX:TermLoanAgreementMember 2021-09-30 0001435064 CETX:AdvancedIndustrialServicesIncMember 2020-01-28 0001435064 CETX:AdvancedIndustrialServicesIncMember 2020-01-27 2020-01-28 0001435064 CETX:AdvancedIndustrialServicesIncMember CETX:FultonBankMember 2020-01-28 0001435064 CETX:AdvancedIndustrialServicesIncMember us-gaap:LondonInterbankOfferedRateLIBORMember 2020-01-28 0001435064 CETX:AdvancedIndustrialServicesIncMember 2022-03-31 0001435064 CETX:AdvancedIndustrialServicesIncMember 2021-09-30 0001435064 CETX:PaycheckProtectionProgramMember 2021-04-30 0001435064 CETX:PaycheckProtectionProgramMember 2021-10-01 2022-03-31 0001435064 CETX:PaycheckProtectionProgramMember 2022-03-31 0001435064 CETX:SeriesOnePreferredStockMember 2021-10-01 2022-03-31 0001435064 us-gaap:SeriesCPreferredStockMember 2019-10-03 0001435064 us-gaap:SeriesCPreferredStockMember 2019-10-02 2019-10-03 0001435064 CETX:NotesPayableMember 2021-10-01 2022-03-31 0001435064 CETX:NotesPayableMember 2022-03-31 0001435064 CETX:NotesPayableMember 2022-02-21 2022-02-22 0001435064 CETX:ISSegmentMember CETX:ManchesterMember 2022-03-31 0001435064 CETX:ISSegmentMember CETX:YorkMember 2022-03-31 0001435064 CETX:ISSegmentMember CETX:EmigsvilleMember 2022-03-31 0001435064 CETX:ISSegmentMember CETX:EmigsvilleMember 2021-10-01 2022-03-31 0001435064 CETX:AdvancedTechnologiesMember CETX:PuneMember 2022-03-31 0001435064 CETX:AdvancedTechnologiesMember CETX:PuneMember 2021-10-01 2022-03-31 0001435064 CETX:AdvancedTechnologiesMember CETX:HauppaugeMember 2022-03-31 0001435064 CETX:AdvancedTechnologiesMember CETX:HauppaugeMember 2021-10-01 2022-03-31 0001435064 CETX:AdvancedTechnologiesMember CETX:HampshireMember 2022-03-31 0001435064 CETX:AdvancedTechnologiesMember CETX:HampshireMember 2021-10-01 2022-03-31 0001435064 us-gaap:SubsequentEventMember CETX:NotesPayableMember 2022-04-01 2022-05-31 0001435064 us-gaap:SubsequentEventMember CETX:SeriesOnePreferredStockMember 2022-04-07 2022-04-07 0001435064 us-gaap:SubsequentEventMember CETX:SeriesOnePreferredStockMember 2022-04-07 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure utr:sqft CETX:Segment iso4217:INR iso4217:GBP

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

☒ | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES ACT OF 1934

For the quarterly period ended March 31, 2022

OR

☐ | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES ACT OF 1934

For the transition period from ___________to ____________

Commission File Number 001-37464

CEMTREX, INC.

(Exact name of registrant as specified in its charter)

Delaware |  | 30-0399914
(State or other jurisdiction of incorporation or organization) |  | (I.R.S. Employer Identification No.)

276 Greenpoint Ave, Suite 208, Brooklyn, NY |  | 11222
(Address of principal executive offices) |  | (Zip Code)

631-756-9116

(Registrant’s telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Act:

Title of each class |  | Trading symbol |  | Name of each exchange on which registered
Common Stock |  | CETX |  | Nasdaq Capital Market
Series 1 Preferred Stock |  | CETXP |  | Nasdaq Capital Market

Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

| ☒ | Yes |  | ☐ | No

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).

| ☒ | Yes |  | ☐ | No

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

| Large accelerated filer ☐ | Accelerated filer ☐
| Non-accelerated filer ☒ | Smaller reporting company ☒
|  | Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).

| ☐ | Yes |  | ☒ | No

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date:

As of May 13, 2022, the issuer had 26,263,296 shares of common stock issued and outstanding.

Table of Contents

CEMTREX, INC. AND SUBSIDIARIES

INDEX

|  | Page
PART I. FINANCIAL INFORMATION |
Item 1. Financial Statements |
| Condensed Consolidated Balance Sheets as of March 31, 2022 (Unaudited) and September 30, 2021 | 3
| Condensed Consolidated Statements of Operations and Comprehensive Income/(Loss) for the three and six months ended March 31, 2022 and March 31, 2021 (Unaudited) | 4
| Condensed Consolidated Statement of Stockholders’ Equity for the six months ended March 31, 2022 (Unaudited) | 5
| Condensed Consolidated Statement of Stockholders’ Equity for the six months ended March 31, 2021 (Unaudited) | 6
| Condensed Consolidated Statements of Cash Flow for the six months ended March 31, 2022 and March 31, 2021 (Unaudited) | 7
| Notes to Unaudited Condensed Consolidated Financial Statements | 9
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations | 21
Item 4. Controls and Procedures | 26
PART II. OTHER INFORMATION |
Item 1. Legal Proceedings | 27
Item 1A Risk Factors | 27
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds | 27
Item 6. Exhibits | 28
SIGNATURES | 30

2

Part I. Financial Information

Item 1. Financial Statements

Cemtrex, Inc. and Subsidiaries

Condensed Consolidated Balance Sheets

|  | (Unaudited) |  |  |  |
|  | March 31, |  |  | September 30, |
|  | 2022 |  |  | 2021 |
Assets |  |  |  |  |  |  |  |
Current assets |  |  |  |  |  |  |  |
Cash and equivalents |  | $ | 8,970,324 |  |  | $ | 15,426,976 |
Restricted cash |  |  | 1,659,905 |  |  |  | 1,759,347 |
Short-term investments |  |  | 4,624,803 |  |  |  | 14,981 |
Trade receivables, net |  |  | 6,005,568 |  |  |  | 7,810,896 |
Trade receivables - related party |  |  | 1,472,514 |  |  |  | 1,487,155 |
Inventory –net of allowance for inventory obsolescence |  |  | 7,066,654 |  |  |  | 5,657,287 |
Prepaid expenses and other assets |  |  | 3,367,643 |  |  |  | 2,585,652 |
Total current assets |  |  | 33,167,411 |  |  |  | 34,742,294 |
Property and equipment, net |  |  | 6,560,246 |  |  |  | 6,738,944 |
Right-of-use assets |  |  | 2,918,671 |  |  |  | 2,940,127 |
Goodwill |  |  | 7,821,283 |  |  |  | 7,821,283 |
Other |  |  | 1,280,386 |  |  |  | 697,240 |
Total Assets |  | $ | 51,747,997 |  |  | $ | 52,939,888 |
Liabilities & Stockholders’ Equity (Deficit) |  |  |  |  |  |  |  |
Current liabilities |  |  |  |  |  |  |  |
Accounts payable |  | $ | 4,764,560 |  |  | $ | 4,235,002 |
Short-term liabilities |  |  | 15,720,515 |  |  |  | 9,977,972 |
Lease liabilities - short-term |  |  | 905,041 |  |  |  | 830,791 |
Deposits from customers |  |  | 184,134 |  |  |  | 536,220 |
Accrued expenses |  |  | 1,309,514 |  |  |  | 1,621,053 |
Deferred revenue |  |  | 2,543,822 |  |  |  | 2,004,170 |
Accrued income taxes |  |  | 135,388 |  |  |  | 448,194 |
Total current liabilities |  |  | 25,562,974 |  |  |  | 19,653,402 |
Long-term liabilities |  |  |  |  |  |  |  |
Loans payable to bank |  |  | 203,547 |  |  |  | 767,279 |
Long-term lease liabilities |  |  | 2,013,630 |  |  |  | 2,017,408 |
Notes payable |  |  | 2,114,322 |  |  |  | 2,350,000 |
Mortgage payable |  |  | 2,207,617 |  |  |  | 2,257,785 |
Other long-term liabilities |  |  | 822,008 |  |  |  | 839,171 |
Paycheck Protection Program Loans |  |  | 103,190 |  |  |  | 1,032,200 |
Deferred Revenue - long-term |  |  | 582,022 |  |  |  | 467,967 |
Total long-term liabilities |  |  | 8,046,336 |  |  |  | 9,731,810 |
Total liabilities |  |  | 33,609,310 |  |  |  | 29,385,212 |
Commitments and contingencies |  |  | - |  |  |  | - |
Shareholders’ equity |  |  |  |  |  |  |  |
Preferred stock , $0.001 par value, 10,000,000 shares authorized, Series 1, 3,000,000 shares authorized, 1,979,753 shares issued and outstanding as of March 31, 2022 and 1,885,151 shares issued and outstanding as of September 30, 2021 (liquidation value of $10 per share) |  |  | 1,980 |  |  |  | 1,885 |
Series C, 100,000 shares authorized, 50,000 shares issued and outstanding at March 31, 2022 and September 30, 2021 |  |  | 50 |  |  |  | 50 |
Preferred stock , value |  |  | 50 |  |  |  | 50 |
Common stock, $0.001 par value, 50,000,000 shares authorized, 24,673,210 shares issued and outstanding at March 31, 2022 and 20,782,194 shares issued and outstanding at September 30, 2021 |  |  | 24,673 |  |  |  | 20,782 |
Additional paid-in capital |  |  | 65,779,736 |  |  |  | 61,727,834 |
Retained earnings (accumulated deficit) |  |  | (51,107,260 | ) |  |  | (41,908,062 | )
Treasury stock at cost |  |  | (148,291 | ) |  |  | (148,291 | )
Accumulated other comprehensive income (loss) |  |  | 2,756,321 |  |  |  | 2,896,452 |
Total Cemtrex stockholders’ equity |  |  | 17,307,209 |  |  |  | 22,590,650 |
Non-controlling interest |  |  | 831,478 |  |  |  | 964,026 |
Total liabilities and shareholders’ equity |  | $ | 51,747,997 |  |  | $ | 52,939,888 |

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

3

Cemtrex, Inc. and Subsidiaries

Condensed Consolidated Statements of Operations and Comprehensive Income/(Loss)

(Unaudited)

|  |  | March 31, 2022 |  |  |  | March 31, 2021 |  |  |  | March 31, 2022 |  |  |  | March 31, 2021 |
|  | For the three months ended |  |  | For the six months ended |
|  | March 31, 2022 |  |  | March 31, 2021 |  |  | March 31, 2022 |  |  | March 31, 2021 |
Revenues |  |  | 12,728,215 |  |  |  | 9,260,385 |  |  |  | 23,400,704 |  |  |  | 18,096,461 |
Cost of revenues |  |  | 8,675,604 |  |  |  | 5,331,501 |  |  |  | 15,478,899 |  |  |  | 10,162,107 |
Gross profit |  |  | 4,052,611 |  |  |  | 3,928,884 |  |  |  | 7,921,805 |  |  |  | 7,934,354 |
Operating expenses |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
General and administrative |  |  | 6,757,233 |  |  |  | 5,249,985 |  |  |  | 13,369,237 |  |  |  | 10,667,181 |
Research and development |  |  | 1,114,715 |  |  |  | 641,497 |  |  |  | 2,426,428 |  |  |  | 1,275,722 |
Total operating expenses |  |  | 7,871,948 |  |  |  | 5,891,482 |  |  |  | 15,795,665 |  |  |  | 11,942,903 |
Operating income/(loss) |  |  | (3,819,337 | ) |  |  | (1,962,598 | ) |  |  | (7,873,860 | ) |  |  | (4,008,549 | )
Other income/(expense) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Other income/(expense) |  |  | 334,931 |  |  |  | 1,679,944 |  |  |  | 1,265,100 |  |  |  | 2,630,932 |
Settlement Agreement - Related Party |  |  | - |  |  |  | 3,674,165 |  |  |  | - |  |  |  | 3,674,165 |
Interest Expense |  |  | (1,317,517 | ) |  |  | (849,076 | ) |  |  | (2,722,986 | ) |  |  | (1,458,017 | )
Total other income/(expense), net |  |  | (982,586 | ) |  |  | 4,505,033 |  |  |  | (1,457,886 | ) |  |  | 4,847,080 |
Net loss before income taxes |  |  | (4,801,923 | ) |  |  | 2,542,435 |  |  |  | (9,331,746 | ) |  |  | 838,531 |
Income tax benefit/(expense) |  |  | - |  |  |  | (98,477 | ) |  |  | - |  |  |  | (127,431 | )
Net income/(loss) |  |  | (4,801,923 | ) |  |  | 2,443,958 |  |  |  | (9,331,746 | ) |  |  | 711,100 |
Less loss in noncontrolling interest |  |  | (80,676 | ) |  |  | (10,174 | ) |  |  | (132,548 | ) |  |  | (50,421 | )
Net income/(loss) attributable to Cemtrex, Inc. shareholders |  | $ | (4,721,247 | ) |  | $ | 2,454,132 |  |  | $ | (9,199,198 | ) |  | $ | 761,521 |
Other comprehensive income/(loss) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Net income/(loss) |  | $ | (4,801,923 | ) |  | $ | 2,443,958 |  |  | $ | (9,331,746 | ) |  | $ | 711,100 |
Foreign currency translation loss |  |  | (199,623 | ) |  |  | (97,423 | ) |  |  | (140,131 | ) |  |  | (40,325 | )
Defined benefit plan actuarial gain |  |  | - |  |  |  | 87,895 |  |  |  | - |  |  |  | 87,895 |
Comprehensive income/(loss) |  |  | (5,001,546 | ) |  |  | 2,434,430 |  |  |  | (9,471,877 | ) |  |  | 758,670 |
Less comprehensive loss attributable to noncontrolling interest |  |  | 80,676 |  |  |  | 10,174 |  |  |  | 132,548 |  |  |  | 50,421 |
Comprehensive income/(loss) attributable to Cemtrex, Inc. shareholders |  | $ | (5,082,222 | ) |  | $ | 2,424,256 |  |  | $ | (9,604,425 | ) |  | $ | 708,249 |
Income/(loss) Per Share-Basic |  | $ | (0.20 | ) |  | $ | 0.13 |  |  | $ | (0.39 | ) |  | $ | 0.04 |
Income/(loss) Per Share-Diluted |  | $ | (0.20 | ) |  | $ | 0.13 |  |  | $ | (0.39 | ) |  | $ | 0.04 |
Weighted Average Number of Shares-Basic |  |  | 24,088,940 |  |  |  | 18,558,843 |  |  |  | 23,588,004 |  |  |  | 18,195,510 |
Weighted Average Number of Shares-Diluted |  |  | 24,088,940 |  |  |  | 18,663,770 |  |  |  | 23,588,004 |  |  |  | 18,203,374 |

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

4

Cemtrex, Inc. and Subsidiaries

Condensed Consolidated Statement of Stockholders’ Equity

(Unaudited)

|  | Shares |  |  | Amount |  |  | Shares |  |  | Amount |  |  | Shares |  |  | Amount |  |  | Shares |  |  | Amount |  |  | Capital |  |  | Deficit) |  |  | At cost |  |  | Income(loss) |  |  |  | Equity |  |  | interest |
|  | Preferred Stock Series 1 |  |  | Preferred Stock Series A |  |  | Preferred Stock Series C |  |  | Common Stock Par |  |  |  |  |  | Retained |  |  |  |  |  | Accumulated |  |  |  |  |  |  |
|  | Par Value $0.001 |  |  | Par Value $0.001 |  |  | Par Value $0.001 |  |  | Value $0.01 |  |  | Additional |  |  | Earnings |  |  | Treasury |  |  | other |  |  | Cemtrex |  |  | Non- |
|  | Number of |  |  |  |  |  | Number of |  |  |  |  |  | Number of |  |  |  |  |  | Number of |  |  |  |  |  | Paid-in |  |  | (Accumulated |  |  | Stock, |  |  | Comprehensive |  |  | Stockholders’ |  |  | controlling |
|  | Shares |  |  | Amount |  |  | Shares |  |  | Amount |  |  | Shares |  |  | Amount |  |  | Shares |  |  | Amount |  |  | Capital |  |  | Deficit) |  |  | At cost |  |  | Income(loss) |  |  | Equity |  |  | interest |
Balance at September 30, 2021 |  |  | 1,885,151 |  |  | $ | 1,885 |  |  |  |  |  |  |  | - |  |  |  | 50,000 |  |  | $ | 50 |  |  |  | 20,782,194 |  |  | $ | 20,782 |  |  | $ | 61,727,834 |  |  | $ | (41,908,062 | ) |  | $ | (148,291 | ) |  | $ | 2,896,452 |  |  | $ | 22,590,650 |  |  | $ | 964,026 |
Foreign currency translation gain/(loss) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 59,492 |  |  |  | 59,492 |  |  |  |  |
Share-based compensation |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 45,371 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 45,371 |  |  |  |  |
Shares issued to pay notes payable |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 2,891,016 |  |  |  | 2,891 |  |  |  | 3,285,180 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 3,288,071 |  |  |  |  |
Dividends paid in Series 1 preferred shares |  |  | 94,602 |  |  |  | 95 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | (95 | ) |  |  |  |  |  |  |  |  |  |  |  |  |  |  | - |  |  |  |  |
Income/(loss) attributable to noncontrolling interest |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | - |  |  |  | (51,872 | )
Net loss |  |  |  |  |  |  | - |  |  |  |  |  |  |  | - |  |  |  |  |  |  |  | - |  |  |  |  |  |  |  | - |  |  |  |  |  |  |  | (4,477,951 | ) |  |  | - |  |  |  |  |  |  |  | (4,477,951 | ) |  |  |  |
Balance at December 31, 2021 |  |  | 1,979,753 |  |  | $ | 1,980 |  |  |  |  |  |  |  | - |  |  |  | 50,000 |  |  | $ | 50 |  |  |  | 23,673,210 |  |  | $ | 23,673 |  |  | $ | 65,058,290 |  |  | $ | (46,386,013 | ) |  | $ | (148,291 | ) |  | $ | 2,955,944 |  |  | $ | 21,505,633 |  |  | $ | 912,154 |
Foreign currency translation gain/(loss) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ | (199,623 | ) |  |  | (199,623 | ) |  |  |  |
Share-based compensation |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ | 27,046 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 27,046 |  |  |  |  |
Shares issued with note payable |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 1,000,000 |  |  | $ | 1,000 |  |  | $ | 694,400 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 695,400 |  |  |  |  |
Income/(loss) attributable to noncontrolling interest |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | - |  |  | $ | (80,676 | )
Net loss |  |  |  |  |  |  | - |  |  |  |  |  |  |  | - |  |  |  |  |  |  |  | - |  |  |  |  |  |  |  | - |  |  |  |  |  |  | $ | (4,721,247 | ) |  |  | - |  |  |  |  |  |  |  | (4,721,247 | ) |  |  |  |
Balance at March 31, 2022 |  |  | 1,979,753 |  |  |  | 1,980 |  |  |  |  |  |  |  | - |  |  |  | 50,000 |  |  |  | 50 |  |  |  | 24,673,210 |  |  |  | 24,673 |  |  |  | 65,779,736 |  |  |  | (51,107,260 | ) |  |  | (148,291 | ) |  |  | 2,756,321 |  |  |  | 17,307,209 |  |  |  | 831,478 |

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

5

Cemtrex, Inc. and Subsidiaries

Condensed Consolidated Statement of Stockholders’ Equity (Continued)

(Unaudited)

|  | Shares |  |  | Amount |  |  | Shares |  |  | Amount |  |  | Shares |  |  | Amount |  |  | Shares |  |  | Amount |  |  | Capital |  |  | Deficit) |  |  | At cost |  |  | Income(loss) |  |  |  | Equity |  |  | interest |
|  | Preferred Stock Series 1 |  |  | Preferred Stock Series A |  |  | Preferred Stock Series C |  |  | Common Stock Par |  |  |  |  |  | Retained |  |  |  |  |  | Accumulated |  |  |  |  |  |  |
|  | Par Value $0.001 |  |  | Par Value $0.001 |  |  | Par Value $0.001 |  |  | Value $0.01 |  |  | Additional |  |  | Earnings |  |  | Treasury |  |  | other |  |  | Cemtrex |  |  | Non- |
|  | Number of |  |  |  |  |  | Number of |  |  |  |  |  | Number of |  |  |  |  |  | Number of |  |  |  |  |  | Paid-in |  |  | (Accumulated |  |  | Stock, |  |  | Comprehensive |  |  | Stockholders’ |  |  | controlling |
|  | Shares |  |  | Amount |  |  | Shares |  |  | Amount |  |  | Shares |  |  | Amount |  |  | Shares |  |  | Amount |  |  | Capital |  |  | Deficit) |  |  | At cost |  |  | Income(loss) |  |  | Equity |  |  | interest |
Balance at September 30, 2020, as restated |  |  | 2,156,784 |  |  | $ | 2,157 |  |  |  | 1,000,000 |  |  | $ | 1,000 |  |  |  | 100,000 |  |  | $ | 100 |  |  |  | 17,622,539 |  |  | $ | 17,623 |  |  | $ | 60,221,766 |  |  | $ | (34,100,067 | ) |  | $ | (148,291 | ) |  | $ | 1,812,457 |  |  | $ | 27,806,745 |  |  | $ | 1,042,300 |
Foreign currency translation gain/(loss) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 37,864 |  |  |  | 37,864 |  |  |  |  |
Share-based compensation |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 16,071 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 16,071 |  |  |  |  |
Shares issued to pay notes payable |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 345,638 |  |  |  | 345 |  |  |  | 407,507 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 407,852 |  |  |  |  |
Dividends paid in Series 1 preferred shares |  |  | 108,169 |  |  |  | 108 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | (108 | ) |  |  |  |  |  |  |  |  |  |  |  |  |  |  | - |  |  |  |  |
Income/(loss) attributable to noncontrolling interest |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | - |  |  |  | (40,247 | )
Net loss |  |  |  |  |  |  | - |  |  |  |  |  |  |  | - |  |  |  |  |  |  |  | - |  |  |  |  |  |  |  | - |  |  |  | - |  |  |  | (1,692,611 | ) |  |  | - |  |  |  | - |  |  |  | (1,692,611 | ) |  |  | - |
Balance at December 31, 2020 |  |  | 2,264,953 |  |  |  | 2,265 |  |  |  | 1,000,000 |  |  |  | 1,000 |  |  |  | 100,000 |  |  |  | 100 |  |  |  | 17,968,177 |  |  |  | 17,968 |  |  |  | 60,645,236 |  |  |  | (35,792,678 | ) |  |  | (148,291 | ) |  |  | 1,850,321 |  |  |  | 26,575,921 |  |  |  | 1,002,053 |
Foreign currency translation gain/(loss) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | (97,423 | ) |  |  | (97,423 | ) |  |  |  |
Defined benefit plan actuarial gain/(loss) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 87,895 |  |  |  | 87,895 |  |  |  |  |
Share-based compensation |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 49,246 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 49,246 |  |  |  |  |
Shares issued to pay notes payable |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 743,286 |  |  |  | 743 |  |  |  | 1,298,733 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 1,299,476 |  |  |  |  |
Income in noncontrolling interest |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | (10,174 | )
Shares and options surrendered in settelment agreement |  |  | (469,949 | ) |  |  | (470 | ) |  |  | (1,000,000 | ) |  |  | (1,000 | ) |  |  | (50,000 | ) |  |  | (50 | ) |  |  |  |  |  |  |  |  |  |  | (3,672,645 | ) |  |  |  |  |  |  |  |  |  |  |  |  |  |  | (3,674,165 | ) |  |  |  |
Net income |  |  |  |  |  |  | - |  |  |  |  |  |  |  | - |  |  |  |  |  |  |  | - |  |  |  |  |  |  |  | - |  |  |  | - |  |  |  | 2,454,132 |  |  |  | - |  |  |  | - |  |  |  | 2,454,132 |  |  |  | - |
Net income/(loss) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 2,454,132 |  |  |  |  |  |  |  |  |  |  |  | 2,454,132 |  |  |  |  |
Balance at March 31, 2021 |  |  | 1,795,004 |  |  |  | 1,795 |  |  |  | - |  |  |  | - |  |  |  | 50,000 |  |  |  | 50 |  |  |  | 18,711,463 |  |  |  | 18,711 |  |  |  | 58,320,570 |  |  |  | (33,338,546 | ) |  |  | (148,291 | ) |  |  | 1,840,793 |  |  |  | 26,695,082 |  |  |  | 991,879 |

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

6

Cemtrex, Inc. and Subsidiaries

Condensed Consolidated Statements of Cash Flows

(Unaudited)

Cash Flows from Operating Activities |  | 2022 |  |  | 2021 |
|  | For the six months ended |
|  | March 31, |
Cash Flows from Operating Activities |  | 2022 |  |  | 2021 |
Net income/(loss) |  | $ | (9,331,746 | ) |  | $ | 711,100 |
Adjustments to reconcile net loss to net cash provided/(used) by operating activities: |  |  |  |  |  |  |  |
Depreciation and amortization |  |  | 862,683 |  |  |  | 680,004 |
Loss on disposal of property and equipment |  |  | 30,558 |  |  |  | 9,219 |
Amortization of right-of-use assets |  |  | 338,643 |  |  |  | 438,539 |
Change in allowance for doubtful accounts |  |  | (1,839 | ) |  |  | (137,356 | )
Share-based compensation |  |  | 72,417 |  |  |  | 65,318 |
Income tax expense/ (benefit) |  |  | - |  |  |  | 127,431 |
Interest expense paid in equity shares |  |  | 1,521,992 |  |  |  | 657,329 |
Accrued interest on notes payable |  |  | 329,264 |  |  |  | 41,833 |
Amortization of original issue discounts on notes payable |  |  | 583,333 |  |  |  | 475,000 |
Gain on marketable securities |  |  | (159,905 | ) |  |  | (1,869,338 | )
Discharge of Paycheck Protection Program Loans |  |  | (971,500 | ) |  |  | - |
Settlement Agreement - Related Party |  |  | - |  |  |  | (3,674,165 | )
Changes in operating assets and liabilities net of effects from acquisition of subsidiaries: |  |  |  |  |  |  |  |
Accounts receivable |  |  | 1,807,167 |  |  |  | 1,420,861 |
Accounts receivable - related party |  |  | 14,641 |  |  |  | (71,581 | )
Inventory |  |  | (1,409,367 | ) |  |  | (565,002 | )
Prepaid expenses and other current assets |  |  | (781,991 | ) |  |  | (631,714 | )
Other assets |  |  | (83,146 | ) |  |  | 169,346 |
Other liabilities |  |  | (17,163 | ) |  |  | 11,438 |
Accounts payable |  |  | 529,558 |  |  |  | (543,272 | )
Operating lease liabilities |  |  | (246,715 | ) |  |  | (450,102 | )
Deposits from customers |  |  | (352,086 | ) |  |  | 66,808 |
Accrued expenses |  |  | (311,539 | ) |  |  | 161,820 |
Deferred revenue |  |  | 653,707 |  |  |  | 138,595 |
Income taxes payable |  |  | (312,806 | ) |  |  | (88,765 | )
Net cash used by operating activities |  |  | (7,235,840 | ) |  |  | (2,856,654 | )
Cash Flows from Investing Activities |  |  |  |  |  |  |  |
Purchase of property and equipment |  |  | (935,499 | ) |  |  | (944,601 | )
Proceeds from sale of property and equipment |  |  | 230,901 |  |  |  | - |
Investment in MasterpieceVR |  |  | (500,000 | ) |  |  | (500,000 | )
Investment in related party |  |  | - |  |  |  | (900,000 | )
Proceeds from sale of marketable securities |  |  | 176,945 |  |  |  | 7,080,375 |
Purchase of marketable securities |  |  | (4,626,862 | ) |  |  | (4,845,903 | )
Net cash used by investing activities |  |  | (5,654,515 | ) |  |  | (110,129 | )
Cash Flows from Financing Activities |  |  |  |  |  |  |  |
Proceeds from notes payable |  |  | 8,000,000 |  |  |  | - |
Payments on notes payable |  |  | (901,763 | ) |  |  | (2,070,257 | )
Payments on bank loans |  |  | (613,900 | ) |  |  | (655,276 | )
Proceeds from Paycheck Protection Program Loans |  |  | - |  |  |  | 1,970,785 |
Net cash provided/(used) by financing activities |  |  | 6,484,337 |  |  |  | (754,748 | )
Effect of currency translation |  |  | (150,076 | ) |  |  | (70,668 | )
Net decrease in cash, cash equivalents, and restricted cash |  |  | (6,406,018 | ) |  |  | (3,721,531 | )
Cash, cash equivalents, and restricted cash at beginning of period |  |  | 17,186,323 |  |  |  | 21,072,859 |
Cash, cash equivalents, and restricted cash at end of period |  | $ | 10,630,229 |  |  | $ | 17,280,660 |
Balance Sheet Accounts Included in Cash, Cash Equivalents, and Restricted Cash |  |  |  |  |  |  |  |
Cash and equivalents |  | $ | 8,970,324 |  |  | $ | 15,573,734 |
Restricted cash |  |  | 1,659,905 |  |  |  | 1,706,926 |
Total cash, cash equivalents, and restricted cash |  | $ | 10,630,229 |  |  | $ | 17,280,660 |

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

7

Cemtrex, Inc. and Subsidiaries

Condensed Consolidated Statements of Cash Flows (Continued)

(Unaudited)

Supplemental Disclosure of Cash Flow Information: |  |  |  |  |  |
Cash paid during the period for interest |  | $ | 288,397 |  |  | $ | 283,855 |
Cash paid during the period for income taxes |  | $ | 312,806 |  |  | $ | 88,765 |
Supplemental Schedule of Non-Cash Investing and Financing Activities |  |  |  |  |  |  |  |
Investment in Virtual Driver Interactive |  | $ | - |  |  | $ | 439,774 |
Stock issued to pay notes payable |  | $ | 3,288,071 |  |  | $ | 1,707,327 |
Shares issued in connection with note payable |  | $ | 700,400 |  |  | $ | - |
Financing of right of use assets |  | $ | 317,187 |  |  | $ | - |

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

8

Cemtrex Inc. and Subsidiaries

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

NOTE 1 – ORGANIZATION AND PLAN OF OPERATIONS

Cemtrex was incorporated in 1998, in the state of Delaware and has evolved through strategic acquisitions and internal growth into a leading multi-industry technology company. The Company has expanded in a wide range of sectors, including smart technologies, virtual and augmented realities, industrial solutions, and intelligent security systems. Unless the context requires otherwise, all references to “we”, “our”, “us”, “Company”, “registrant”, “Cemtrex” or “management” refer to Cemtrex, Inc. and its subsidiaries.

The Company has two business segments, consisting of (i) Advanced Technologies (AT) and (ii) Industrial Services (IS).

Advanced Technologies (AT)

Cemtrex’s Advanced Technologies segment operates several brands that deliver cutting-edge software and hardware technologies:

| - | Vicon Industries – Vicon Industries, a majority owned subsidiary, provides end-to-end video security solutions to meet the toughest corporate, industrial and governmental security challenges. Vicon’s products include browser-based video monitoring systems and analytics-based recognition systems, cameras, servers, and access control systems for every aspect of security and surveillance in industrial and commercial facilities, federal prisons, hospitals, universities, schools, and federal and state government offices. Vicon provides cutting edge, mission critical security and video surveillance solutions utilizing Artificial Intelligence (AI) based data algorithms.
| - | SmartDesk – SmartDesk is focused on reinventing the workspace through developing state-of-the-art, modern, fully integrated, workplace solutions.
| - | Cemtrex XR (“CXR”) – CXR is focused on realizing the potential of the metaverse. CXR delivers Virtual Reality (VR) and Augmented Reality (AR) solutions that provide higher productivity, progressive design and impactful experiences for consumer products, and various commercial and industrial applications. The Company is in the process of developing virtual reality applications for commercialization in the metaverse over the next couple years. CXR also invests in emerging startups focused on building best in class solutions for the metaverse.
| - | Virtual Driver Interactive (“VDI”) – VDI provides innovative driver training simulation solutions for effective and engaging learning for all ages and skills.
| - | Bravo Strong – Bravo Strong is a gaming and content studio working to building games and experiences for the metaverse.
| - | good tech (formerly Cemtrex Labs) – good tech provides mobile, web, and enterprise software application development services for startups to large enterprises.

Industrial Services (IS)

Cemtrex’s IS segment operates through a brand, Advanced Industrial Services (“AIS”), that offers single-source expertise and services for rigging, millwrighting, in plant maintenance, equipment erection, relocation, and disassembly to diversified customers. We install high precision equipment in a wide variety of industrial markets like automotive, printing & graphics, industrial automation, packaging, and chemicals among others. We are a leading provider of reliability-driven maintenance and contracting solutions for the machinery, packaging, printing, chemical, and other manufacturing markets. The focus is on customers seeking to achieve greater asset utilization and reliability to cut costs and increase production from existing assets, including small projects, sustaining capital, turnarounds, maintenance, specialty welding services, and high-quality scaffolding.

9

Acquisition of Virtual Driver Interactive

On October 26, 2020, the company acquired Virtual Driver Interactive (“VDI”), a California based provider of innovative driver training simulation solutions for a purchase price of $1,339,774 plus contingent consideration of $175,428.

For over 10 years, VDI has been known for its effective and engaging driver training systems, designed for users of all ages and skill levels. The Company offers comprehensive training for new teen and novice drivers, along with advanced training for corporate fleets and truck drivers. VDI’s wide range of training courses and system options provide customers with highly portable, affordable and effective solutions, all while focusing on the dangers of distracted driving. Results for VDI will be reported under the AT segment.

The Company paid $900,000 in cash and issued a note payable in the amount of $439,774. This note carries interest of 5% and is payable in two installments of $239,774 plus accumulated interest on October 26, 2021, and $200,000 plus accumulated interest on October 26, 2022. Additionally, the Company paid contingent consideration of $175,428 in May 2021. There is no further contingent consideration specified in the purchase agreement. The Company has accounted for this acquisition as a business combination and has allocated the purchase price as follows, $876,820 to proprietary software, $39,992 to inventory, and $598,391 to goodwill.

Strategic Investment

On November 13, 2020, Cemtrex made a $500,000 investment and on January 19, 2022 made an additional $500,000 investment via a simple agreement for future equity(“SAFE”) in MasterpieceVR. The SAFE provides that the Company will automatically receive shares of the entity based on the conversion rate of future equity rounds up to a valuation cap, as defined. MasterpieceVR is a software company that is developing software for content creation using virtual reality. The investment is included in other assets in the accompanying balance sheet and the Company accounts for this investment and recorded at cost. No impairment has been recorded for the period ended March 31, 2022.

Potential Impacts of COVID-19 on our Business

The current COVID-19 pandemic has impacted our business operations and the results of our operations in the last fiscal year, primarily with delays in expected orders by many customers and new product development, including newer versions of surveillance software since our technical facility in Pune, India has been under lock down on multiple occasions. Overall bookings level in the IS segment of our business were down by more than 20%, however our AT segment had experienced relatively less slow down. Bookings and revenue are starting to show signs of recovery in this fiscal quarter compared to the same period last year. However, due to delays in certain supply chain areas, the expected launch times of our new products and new versions has resulted in delays of several months. Additionally, increased prices and the need to increase wages to retain talent may cause our gross margin percentages to shrink and our operational costs to rise.

The broader implications of COVID-19 on our results from operations going forward remains uncertain. The COVID-19 pandemic and the resulting supply chain issues and inflation has the potential to cause adverse effects to our customers, suppliers or business partners in locations that have or will experience more pronounced disruptions, which could result in a reduction to future revenue and manufacturing output as well as delays in our new product development activities. However, opportunities in the video surveillance field have been growing for Vicon products.

The extent of the pandemics effect on our operational and financial performance will depend in large part on future developments, which cannot be reasonably estimated at this time. Future developments include the duration, scope and severity of the pandemic, the emergence of new virus variants that are more contagious or harmful than prior variants, the actions taken to contain or mitigate its impact both within and outside the jurisdictions where we operate, the impact on governmental programs and budgets, the development of treatments or vaccines, and the resumption of widespread economic activity. Due to the inherent uncertainty of the unprecedented and rapidly evolving situation, we are unable to predict with any confidence the likely impact of the COVID-19 pandemic on our future operations.

10

NOTE 2 – INTERIM STATEMENT PRESENTATION

Basis of Presentation and Use of Estimates

The accompanying unaudited condensed consolidated financial information should be read in conjunction with the audited consolidated financial statements and the notes thereto included in the Annual Report on Form 10-K for the year ended September 30, 2021, of Cemtrex Inc.

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the Unites States (“US GAAP”) for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X pursuant to the requirements of the U.S. Securities and Exchange Commission (‘SEC”). Accordingly, they do not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring adjustments) considered necessary for a fair presentation have been included. The results of operations for the interim periods are not necessarily indicative of the results of operations for the entire year.

The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities as of the date of the condensed consolidated financial statements, the disclosure of contingent assets and liabilities in the condensed consolidated financial statements and the accompanying notes, and the reported amounts of revenues, expenses and cash flows during the periods presented. Actual amounts and results could differ from those estimates. The estimates and assumptions the Company makes are based on historical factors, current circumstances and the experience and judgment of the Company’s management. The Company evaluates its estimates and assumptions on an ongoing basis.

The condensed consolidated financial statements include the accounts of the Company, its wholly owned subsidiaries, Cemtrex Advanced Technologies Inc., Cemtrex Technologies Pvt. Ltd., Cemtrex XR Inc., and Advanced Industrial Services, Inc. and the Company’s majority owned subsidiary Vicon Industries, Inc. and its subsidiary, Vicon Industries Ltd. All inter-company balances and transactions have been eliminated in consolidation.

Accounting Pronouncements

Significant Accounting Policies

Note 2 of the Notes to Consolidated Financial Statements, included in the annual report on Form 10-K for the year ended September 30, 2021, includes a summary of the significant accounting policies used in the preparation of the consolidated financial statements.

Recently Issued Accounting Standards

ASU 2016-13 Measurement of Credit Losses on Financial Instrument is effective for fiscal years beginning after December 15, 2022. This is not expected to apply to the Company as financial instruments giving rise to credit risk are not utilized by the Company.

In May 2021, the FASB issued ASU 2021-04, Earnings Per Share (Topic 260), Debt-Modifications and Extinguishments (Subtopic 470-50), Compensation-Stock Compensation (Topic 718), and Derivatives and Hedging-Contracts in Entity’s Own Equity (Subtopic 815-40). The new ASU addresses issuer’s accounting for certain modifications or exchanges of freestanding equity-classified written call options. This amendment is effective for all entities, for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. Early adoption is permitted. The Company is currently evaluating the impact this new guidance will have on its financial statements.

The Company does not believe that any other recently issued but not yet effective accounting pronouncements, if adopted, would have a material effect on the accompanying consolidated financial statements.

11

NOTE 3 – LOSS PER COMMON SHARE

Basic net income (loss) per common share is computed by dividing net income (loss) by the weighted average number of shares of common stock outstanding during the period. Diluted net income per common share is computed by dividing net income by the weighted average number of shares of common stock and potentially dilutive outstanding shares of common stock during the period to reflect the potential dilution that could occur from common shares issuable through contingent share arrangements, stock options and warrants. For the three and six months ended March 31, 2022, and 2021, the following items were excluded from the computation of diluted net loss per common share as their effect is anti-dilutive:

SCHEDULE OF COMPUTATION OF DILUTED NET LOSS PER COMMON SHARE AS ANTI-DILUTIVE EFFECT

|  | 2022 |  |  | 2021 |  |  | 2022 |  |  | 2021 |
|  | For the three months ended |  |  | For the six months ended |
|  | March 31, |  |  | March 31, |
|  | 2022 |  |  | 2021 |  |  | 2022 |  |  | 2021 |
Warrants to purchase shares |  |  | - |  |  |  | 433,965 |  |  |  | - |  |  |  | 433,965 |
Options |  |  | 800,000 |  |  |  | 880,049 |  |  |  | 800,000 |  |  |  | 944,757 |
Net loss per common share anti-dilutive effect |  |  | 800,000 |  |  |  | 880,049 |  |  |  | 800,000 |  |  |  | 944,757 |

NOTE 4 – SEGMENT INFORMATION

The Company reports and evaluates financial information for two segments: Advanced Technologies (AT) segment, and the Industrial Services (IS) segment. The AT segment develops smart devices and provides progressive design and development solutions to create impactful experiences for mobile, web, virtual and augmented reality, wearables and television as well as providing cutting edge, mission critical security and video surveillance. The IS segment offers single-source expertise and services for rigging, millwrighting, in plant maintenance, equipment erection, relocation, and disassembly to diversified customers in USA in industries such as: manufacturing, steel, printing, construction, & petrochemical.

The following tables summarize the Company’s segment information:

SCHEDULE OF SEGMENT INFORMATION

|  | 2022 |  |  | 2021 |  |  | 2022 |  |  | 2021 |
|  | For the three months ended |  |  | For the six months ended |
|  | March 31, |  |  | March 31, |
|  | 2022 |  |  | 2021 |  |  | 2022 |  |  | 2021 |
Revenues from external customers |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Advanced Technologies |  | $ | 7,722,307 |  |  | $ | 5,487,414 |  |  | $ | 13,340,824 |  |  | $ | 10,160,283 |
Industrial Services |  | $ | 5,005,908 |  |  |  | 3,772,971 |  |  |  | 10,059,880 |  |  |  | 7,936,178 |
Total revenues |  | $ | 12,728,215 |  |  | $ | 9,260,385 |  |  | $ | 23,400,704 |  |  | $ | 18,096,461 |
Gross profit |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Advanced Technologies |  | $ | 2,586,593 |  |  | $ | 2,646,926 |  |  | $ | 5,025,602 |  |  | $ | 4,993,198 |
Industrial Services |  |  | 1,466,018 |  |  |  | 1,281,958 |  |  |  | 2,896,203 |  |  |  | 2,941,156 |
Total gross profit |  | $ | 4,052,611 |  |  | $ | 3,928,884 |  |  | $ | 7,921,805 |  |  | $ | 7,934,354 |
Operating income/(loss) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Advanced Technologies |  | $ | (4,810,095 | ) |  | $ | (1,693,377 | ) |  | $ | (9,826,559 | ) |  | $ | (3,535,723 | )
Industrial Services |  |  | 990,758 |  |  |  | (269,221 | ) |  |  | 1,952,699 |  |  |  | (472,826 | )
Total operating loss |  | $ | (3,819,337 | ) |  | $ | (1,962,598 | ) |  | $ | (7,873,860 | ) |  | $ | (4,008,549 | )
Other income/(expense) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Advanced Technologies |  | $ | (963,668 | ) |  | $ | 3,769,515 |  |  | $ | (1,387,920 | ) |  | $ | 4,136,750 |
Industrial Services |  |  | (18,918 | ) |  |  | 735,518 |  |  |  | (69,966 | ) |  |  | 710,330 |
Total other expense |  | $ | (982,586 | ) |  | $ | 4,505,033 |  |  | $ | (1,457,886 | ) |  | $ | 4,847,080 |
Depreciation and Amortization |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Advanced Technologies |  | $ | 423,360 |  |  | $ | 89,746 |  |  | $ | 506,970 |  |  | $ | 205,578 |
Industrial Services |  |  | 176,490 |  |  |  | 229,680 |  |  |  | 355,713 |  |  |  | 474,426 |
Total depreciation and amortization |  | $ | 599,850 |  |  | $ | 319,426 |  |  | $ | 862,683 |  |  | $ | 680,004 |

|  | March 31, |  |  | September 30, |
|  | 2022 |  |  | 2021 |
Identifiable Assets |  |  |  |  |  |  |  |
Advanced Technologies |  | $ | 33,772,905 |  |  | $ | 33,850,496 |
Industrial Services |  |  | 17,975,092 |  |  |  | 19,089,392 |
Total Assets |  | $ | 51,747,997 |  |  | $ | 52,939,888 |

12

NOTE 5 – FAIR VALUE MEASUREMENTS

Fair value is defined as the price that would be received upon sale of an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. A three-level hierarchy is applied to prioritize the inputs to valuation techniques used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements).

The three levels of the fair value hierarchy under the guidance for fair value measurements are described below:

Level 1 — Level 1 inputs are quoted prices (unadjusted) in active markets for identical assets or liabilities that the reporting entity has the ability to access at the measurement date. Our Level 1 assets include cash equivalents, banker’s acceptances, trading securities investments and investment funds. We measure trading securities investments and investment funds at quoted market prices as they are traded in an active market with sufficient volume and frequency of transactions.

Level 2 — Level 2 inputs are inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly. If the asset or liability has a specified contractual term, a Level 2 input must be observable for substantially the full term of the asset or liability.

Level 3 — Level 3 inputs are unobservable inputs for the asset or liability in which there is little, if any, market activity for the asset or liability at the measurement date. Level 3 assets and liabilities include cost method investments. Quantitative information for Level 3 assets and liabilities reviewed at each reporting period includes indicators of significant deterioration in the earnings performance, credit rating, asset quality, business prospects of the investee, and financial indicators of the investee’s ability to continue as a going concern.

The Company’s fair value assets at March 31, 2022 and September 30, 2021, are as follows.

SCHEDULE OF FAIR VALUE OF ASSETS

|  | Quoted Prices |  |  | Significant |  |  |  |  |  |  |
|  | in Active |  |  | Other |  |  | Significant |  |  | Balance |
|  | Markets for |  |  | Observable |  |  | Unobservable |  |  | as of |
|  | Identical Assets |  |  | Inputs |  |  | Inputs |  |  | March 31, |
|  | (Level 1) |  |  | (Level 2) |  |  | (Level 3) |  |  | 2022 |
Assets |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Investment in marketable securities |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
(included in short-term investments) |  | $ | 4,624,803 |  |  | $ | - |  |  | $ | - |  |  | $ | 4,624,803 |
|  | $ | 4,624,803 |  |  | $ | - |  |  | $ | - |  |  | $ | 4,624,803 |

|  | Quoted Prices |  |  | Significant |  |  |  |  |  |  |
|  | in Active |  |  | Other |  |  | Significant |  |  | Balance |
|  | Markets for |  |  | Observable |  |  | Unobservable |  |  | as of |
|  | Identical Assets |  |  | Inputs |  |  | Inputs |  |  | September, 30 |
|  | (Level 1) |  |  | (Level 2) |  |  | (Level 3) |  |  | 2021 |
Assets |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Investment in marketable securities |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
(included in short-term investments) |  | $ | 14,981 |  |  | $ | - |  |  | $ | - |  |  | $ | 14,981 |
Fair value assets |  | $ | 14,981 |  |  | $ | - |  |  | $ | - |  |  | $ | 14,981 |

NOTE 6 – RESTRICTED CASH

A subsidiary of the Company participates in a consortium in order to self-insure group care coverage for its employees. The plan is administrated by Benecon Group and the Company makes monthly deposits in a trust account to cover medical claims and any administrative costs associated with the plan. These funds, as required by the plan are restricted in nature and amounted to $1,502,490 at March 31, 2022 and $1,601,932 at September 30, 2021. Additionally, the Company has a standby letter of credit for deposit on a building lease and payable against a money market account. The amount of the standby letter of credit is $157,415 as of March 31, 2022 and September 30, 2021.

13

NOTE 7 – ACCOUNTS RECEIVABLE, NET

Accounts receivables, net consist of the following:

SCHEDULE OF ACCOUNTS RECEIVABLE, NET

|  | March 31, |  |  | September 30, |
|  | 2022 |  |  | 2021 |
Accounts receivable |  | $ | 6,182,721 |  |  | $ | 7,989,888 |
Allowance for doubtful accounts |  |  | (177,153 | ) |  |  | (178,992 | )
Accounts receivables, net, total |  | $ | 6,005,568 |  |  | $ | 7,810,896 |

Accounts receivable include amounts due for shipped products and services rendered.

Allowance for doubtful accounts include estimated losses resulting from the inability of our customers to make required payments.

NOTE 8 – INVENTORY, NET

Inventory, net, consist of the following:

SCHEDULE OF INVENTORY, NET

|  | March 31, |  |  | September 30, |
|  | 2022 |  |  | 2021 |
Raw materials |  | $ | 2,414,149 |  |  | $ | 1,957,410 |
Work in progress |  |  | 830,950 |  |  |  | 429,871 |
Finished goods |  |  | 5,638,355 |  |  |  | 5,191,007 |
Inventory, gross |  |  | 8,883,454 |  |  |  | 7,578,288 |
Less: Allowance for inventory obsolescence |  |  | (1,816,800 | ) |  |  | (1,921,001 | )
Inventory –net of allowance for inventory obsolescence |  | $ | 7,066,654 |  |  | $ | 5,657,287 |

NOTE 9 – PROPERTY AND EQUIPMENT

Property and equipment are summarized as follows:

SUMMARY OF PROPERTY AND EQUIPMENT

|  | March 31, |  |  | September 30, |
|  | 2022 |  |  | 2021 |
Land |  | $ | 790,373 |  |  | $ | 790,373 |
Building and leasehold improvements |  |  | 2,930,735 |  |  |  | 2,892,900 |
Furniture and office equipment |  |  | 534,185 |  |  |  | 501,885 |
Computers and software |  |  | 1,313,816 |  |  |  | 1,105,681 |
Machinery and equipment |  |  | 12,865,786 |  |  |  | 12,984,959 |
Property and equipment, gross |  |  | 18,434,895 |  |  |  | 18,275,798 |
Less: Accumulated depreciation |  |  | (11,874,649 | ) |  |  | (11,536,854 | )
Property and equipment, net |  | $ | 6,560,246 |  |  | $ | 6,738,944 |

Depreciation expense for the three months ended March 31, 2022, and 2021 were $599,850, $319,426, respectively, and for the six months ended March 31, 2022, and 2021 were $862,683, $680,004, respectively.

14

NOTE 10 – LEASES

ASC 842, “Leases”, requires that a lessee recognize the assets and liabilities that arise from operating leases. A lessee should recognize in the statement of financial position a liability to make lease payments (the lease liability) and a right-of-use asset representing its right to use the underlying asset for the lease term. For leases with a term of 12 months or less, a lessee is permitted to make an accounting policy election by class of underlying asset not to recognize lease assets and lease liabilities. In transition, lessees and lessors are required to recognize and measure leases at either the effective date (the “effective date method”) or the beginning of the earliest period presented (the “comparative method”) using a modified retrospective approach. Under the effective date method, the Company’s comparative period reporting is unchanged. In contrast, under the comparative method, the Company’s date of initial application is the beginning of the earliest comparative period presented, and the Topic 842 transition guidance is then applied to all comparative periods presented. Further, under either transition method, the standard includes certain practical expedients intended to ease the burden of adoption. The Company adopted ASC 842 October 1, 2019, using the effective date method and elected certain practical expedients allowing the Company not to reassess:

| ● | whether expired or existing contracts contain leases under the new definition of a lease;
| ● | lease classification for expired or existing leases; and
| ● | whether previously capitalized initial direct costs would qualify for capitalization under Topic 842.

The Company also made the accounting policy decision not to recognize lease assets and liabilities for leases with a term of 12 months or less.

The Company entered into a financing lease for a single vehicle in the Industrial services segment with a term of 3 years. The Company entered into operating leases for its facilities in New York, United Kingdom, and India, as well as for vehicles for use in our Industrial Services segment. The operating lease terms range from 2 to 7 years. The Company excluded the renewal option on its applicable facility leases from the calculation of its right-of-use assets and lease liabilities.

Finance and operating lease liabilities consist of the following:

SUMMARY OF FINANCE AND OPERATING LEASE LIABILITIES

|  | March 31, |  |  | September 30, |
|  | 2021 |  |  | 2021 |
Lease liabilities - current |  |  |  |  |  |  |  |
Finance leases |  | $ | - |  |  | $ | - |
Operating leases |  |  | 905,041 |  |  |  | 830,791 |
|  |  | 905,041 |  |  |  | 830,791 |
Lease liabilities - net of current portion |  |  |  |  |  |  |  |
Finance leases |  | $ | - |  |  | $ | - |
Operating leases |  |  | 2,013,630 |  |  |  | 2,017,408 |
|  | $ | 2,013,630 |  |  | $ | 2,017,408 |

15

A reconciliation of undiscounted cash flows to finance and operating lease liabilities recognized in the condensed consolidated balance sheet at March 31, 2022, is set forth below:

SCHEDULE OF RECONCILIATION OF UNDISCOUNTED CASH FLOWS TO FINANCE AND OPERATING LEASE LIABILITIES

Years ending September 30, |  | Finance leases |  |  | Operating Leases |  |  | Total |
2022 |  |  | - |  |  |  | 604,963 |  |  |  | 604,963 |
2023 |  |  | - |  |  |  | 784,504 |  |  |  | 784,504 |
2024 |  |  | - |  |  |  | 660,865 |  |  |  | 660,865 |
2025 |  |  | - |  |  |  | 638,531 |  |  |  | 638,531 |
2026 & Thereafter |  |  | - |  |  |  | 702,252 |  |  |  | 702,252 |
Undiscounted lease payments |  |  | - |  |  |  | 3,391,115 |  |  |  | 3,391,115 |
Amount representing interest |  |  | - |  |  |  | (472,444 | ) |  |  | (472,444 | )
Discounted lease payments |  | $ | - |  |  | $ | 2,918,671 |  |  | $ | 2,918,671 |

Additional disclosures of lease data are set forth below:

SCHEDULE OF LEASE COSTS

|  | Six months ended |
|  | March 31, 2022 |  |  | March 31, 2021 |
Lease costs: |  |  |  |  |  |  |  |
Finance lease costs: |  |  |  |  |  |  |  |
Depreciation of finance lease assets |  | $ | - |  |  | $ | 5,728 |
Interest on lease liabilities |  |  | - |  |  |  | 27 |
Operating lease costs: |  |  |  |  |  |  |  |
Amortization of right-of-use assets |  |  | 338,643 |  |  |  | 186,777 |
Interest on lease liabilities |  |  | 30,720 |  |  |  | 16,636 |
Total lease cost |  | $ | 369,363 |  |  | $ | 209,168 |
Other information: |  |  |  |  |  |  |  |
Cash paid for amounts included in the measurement of lease liabilities: |  |  |  |  |  |  |  |
Operating leases |  | $ | 246,715 |  |  | $ | 178,228 |
Finance leases |  |  | - |  |  |  | 14,306 |
|  | $ | 246,715 |  |  | $ | 192,534 |
Weighted-average remaining lease term - finance leases (months) |  |  | 0 |  |  |  | 7 |
Weighted-average remaining lease term - operating leases (months) |  |  | 36 |  |  |  | 48 |
Weighted-average discount rate - finance leases |  |  | N/A |  |  |  | 3.63 | %
Weighted-average discount rate - operating leases |  |  | 5.66 | % |  |  | 6.64 | %

The Company used the rate implicit in the lease, where known, or its incremental borrowing rate as the rate used to discount the future lease payments.

NOTE 11 – PREPAID AND OTHER CURRENT ASSETS

On March 31, 2022, the Company had prepaid and other current assets consisting of prepayments on inventory purchases of $630,165, costs and estimated earnings in excess of billings on uncompleted contracts of $1,102,347, and other current assets of $1,635,131. On September 30, 2021, the Company had prepaid and other current assets consisting of prepayments on inventory purchases of $298,707, costs and estimated earnings in excess of billings on uncompleted contracts of $1,148,243, and other current assets of $1,138,702.

16

NOTE 12 – OTHER ASSETS

As of March 31, 2022, the Company had other assets of $1,280,386 which was comprised of rent security of $90,791, a strategic investment in MasterpieceVR of $1,000,000, and other assets of $189,585. As of September 30, 2021, the Company had other assets of $697,240 which was comprised of rent security deposits of $84,362, Investment in Masterpiece VR valued at $500,000, and other assets of $112,878.

NOTE 13 – RELATED PARTY TRANSACTIONS

On August 31, 2019, the Company entered into an Asset Purchase Agreement for the sale of Griffin Filters, LLC to Ducon Technologies, Inc., which Aron Govil, the Company’s Founder and former CFO, is President, for total consideration of $550,000. As of March 31, 2022, and September 30, 2021, there was $1,472,514 and $1,487,155 in receivables due from Ducon Technologies, Inc., respectively. At March 31, 2022, $500,000 of the balance due is for the sale of Griffin, which was due in February 2021, and the remaining balance are various receivables with various due dates within the next fiscal year. The Company is currently negotiating a payment agreement surrounding all these amounts due.

On February 23, 2021, Cemtrex’s Board of Directors determined that certain transactions between Cemtrex Inc. and First Commercial, a company owned by former Executive Director, former Controlling Shareholder and former CFO, Aron Govil, were incorrectly handled and accounted for.

The total amount of disputed transfers was approximately $7,100,000 and occurred in fiscal year 2017 in the amount of $5,600,000 and in fiscal year 2018 in the amount of $1,500,000. Cemtrex did not find any other such transfers during this period or thereafter, upon further review of the Company’s records.

Upon the Company’s investigation into this matter, the Company has determined that there were inaccuracies in the Company’s financial statements. The financials for the periods 2017 and 2018 were incorrect corresponding to the amounts that were incorrectly accounted for, and subsequent years were affected by the roll forward effects of these entries. The Company found unsupported advertising expenses in the amount of approximately $400,000 on Cemtrex Inc’s income statement for fiscal year 2018 and found that approximately $5,700,000 of intangible assets and $975,000 of research and development expenses, as translated from Indian Rupee at the time, were recorded on Cemtrex India’s financial statements in fiscal year 2018 and could not be substantiated. The total amount of unsubstantiated transfers recorded by Cemtrex India, and the unsupported advertising expense recorded by Cemtrex, Inc. sums to $7,100,000, corresponding with the total amount in question regarding First Commercial transfers during fiscal years 2017 and 2018

On February 26, 2021, the Company entered into a Settlement Agreement and Release with Aron Govil regarding these transactions.

As part of the Settlement Agreement, Mr. Govil was required to pay the Company consideration with a total value of $7,100,000 (the “Settlement Amount”) by entering into the Agreement. The Settlement Amount was satisfied in a combination of Mr. Govil forfeiting certain Preferred Stock and outstanding options and executing a secured note in the amount of $1,533,280. The Independent Board of Directors in coordination with Management concluded the settlement represented fair value.

In March 2021, Mr. Govil returned to the Company 1,000,000 shares of Series A Preferred Stock, 50,000 Shares of Series C Preferred Stock, 469,949 shares of Series 1 Preferred Stock, and forfeited all outstanding options to purchase shares of commons stock (collectively, the “Securities”). For the purposes of accounting recognition, the Company determined the fair value of the Series A, Series C, and Series 1 Preferred stock based on the closing trading value of the Series 1 Preferred Stock on the date of the agreement. The options surrendered were valued using the Black-Scholes option pricing model.

The Company recognized the gain with respect to the surrendered Securities during the second quarter of fiscal year 2021. The gain of $3,674,165 is reported as Settlement Agreement – Related Party on the Company’s Condensed Consolidated Statements of Operations and Comprehensive Income/(Loss).

As discussed above, Mr. Govil also executed a secured promissory note (the “Note”) in the amount of $1,533,280. The Note matures and is due in full in two years and bears interest at 9% per annum and is secured by all of Mr. Govil’s assets. Mr. Govil also agreed to sign an affidavit confessing judgment in the event of a default on the Note. While the Company believes the note is fully collectible, in accordance with ASC 450-30, Gain Contingencies, the Company determined the gain will not be recognized until the note is paid. Accordingly, the note and associated gain is not presented on the Company’s Condensed Consolidated Balance Sheets and Condensed Consolidated Statements of Operations and Comprehensive Income/(Loss).

17

NOTE 14 – LINES OF CREDIT AND LONG-TERM LIABILITIES

Lines of credit

The Company currently has a line of credit with Fulton Bank for $3,500,000. The line carries an interest of LIBOR plus 2.00% per annum (2.783% as of March 31, 2022 and 2.075% as of September 30, 2021). At March 31, 2022 and September 30, 2021, there was no outstanding balance on this line of credit. The terms of this line of credit are subject to the bank’s review annually on February 1.

Loans payable to bank

On December 15, 2015, the Company acquired a loan from Fulton Bank in the amount of $5,250,000 in order to fund the purchase of Advanced Industrial Services, Inc. $5,000,000 of the proceeds went to direct purchase of AIS. This loan carries interest of LIBOR plus 2.25% per annum (3.033% as of March 31, 2022 and 2.325% as of September 30, 2021) and is payable on December 15, 2022. This loan carries loan covenants which the Company was in compliance with as of March 31, 2022. The outstanding balance on this loan was $735,494 and $1,218,680, on March 31, 2022, and September 30, 2021, respectively. This loan is secured by the assets of the Company.

On May 1, 2018, the Company acquired a loan from Fulton Bank in the amount of $400,000 in order to fund new equipment for Advanced Industrial Services, Inc. This loan carries interest of LIBOR plus 2.00% per annum (2.783% as of March 31, 2022 and 2.075% as of September 30, 2021) and is payable on May 1, 2023. This loan carries loan covenants which the Company was in compliance with as of March 31, 2022. The outstanding balance on this loan was $106,799 and $149,914, on March 31, 2022, and September 30, 2021, respectively. This loan is secured by the assets of the Company

On January 28, 2020, the Company acquired a loan from Fulton Bank in the amount of $360,000 in order to fund new equipment for Advanced Industrial Services, Inc. This loan carries interest of LIBOR plus 2.25% per annum (3.033% as of March 31, 2022 and 2.325% as of September 30, 2021) and is payable on May 1, 2023. This loan carries loan covenants which the Company was in compliance with as of March 31, 2022. The outstanding balance on this loan was $220,630 and $258,060, on March 31, 2022, and September 30, 2021, respectively. This loan is secured by the assets of the Company

Notes payable

On September 30, 2020, the Company, issued a note payable to an independent private lender in the amount of $4,605,000. This note carried interest of 8% and matured on March 30, 2022. After deduction of an original issue discount of $600,000 and legal fees of $5,000, the Company received $4,000,000 in cash. As of March 31, 2022, and September 30, 2021, this note had a balance of $0 and $2,256,448, respectively. As of March 31, 2022, and September 31, 2021, this note had unamortized original issue discount balance of $0 and $200,000, respectively

On September 30, 2021, the Company, issued a note payable to an independent private lender in the amount of $5,755,000. This note carries interest of 8% and matures on March 30, 2023. After deduction of an original issue discount of $750,000 and legal fees of $5,000, the Company received $5,000,000 in cash. As of March 31, 2022, and September 30, 2021, this note had a balance of $5,992,502 and $5,005,000, respectively. As of March 31, 2022, and September 31, 2021, this note had unamortized original issue discount balance of $500,000 and $750,000, respectively.

On February 22, 2022, the Company, issued a note payable to an independent private lender in the amount of $9,205,000. This note carries interest of 8% and matures on August 22, 2023. After deduction of an original issue discount of $1,200,000 and legal fees of $5,000, the Company received $8,000,000 in cash. Additionally, the Company issued 1,000,000 shares of its common stock to the lender. The fair market value of the stock of $700,400 was recognized as interest expense on the Company’s Condensed Consolidated Statement of Operations and Comprehensive Income/(Loss). As of March 31, 2022, this note had a balance of $9,280,989. As of March 31, 2022, this note had unamortized original issue discount balance of $1,066,667.

18

On March 30, 2022, Vicon, a subsidiary of the Company, amended the $5,600,000 Term Loan Agreement with NIL Funding Corporation (“NIL”). Upon closing, $500,000 of outstanding borrowings were repaid to NIL. The Agreement requires monthly payments of accrued interest that began on October 1, 2018. This note carries interest of 8.85% and matures on March 30, 2023. This note carries loan covenants which the Company is in compliance with as of March 31, 2022. As of March 31, 2022, and September 30, 2021, this note had a balance of $2,954,743 and $3,604,743, respectively.

Mortgage Payable

On January 28, 2020, the Company’s subsidiary, Advanced Industrial Services, Inc., completed the purchase of two buildings for a total purchase price of $3,381,433. The Company paid $905,433 in cash and acquired a mortgage from Fulton Bank in the amount of $2,476,000. This mortgage carries interest of LIBOR plus 2.50% per annum (3.283% as of March 31, 2022 and 2.575% as of September 30, 2021) and is payable on January 28, 2040. This loan carries loan covenants similar to covenants on the Company’s other loans from Fulton Bank. As of March 31, 2022, the Company was in compliance with these covenants. As of March 31, 2022, and September 30, 2021, this mortgage had a balance of $2,228,945 and $2,339,114, respectively.

Paycheck Protection Program Loans

In April and May of 2020, and January and April of 2021, the Company and its subsidiaries applied for and were granted $6,413,385 in Paycheck Protection Program loans under the CARES Act. These loans bear interest of 2% and mature in two years. The Company has applied for and received loan forgiveness under the provisions of the CARES Act for $6,291,985. The remaining loan of $121,400 has been modified with a maturity date of May 5, 2025 and payments starting in June of 2022 and is recorded under Paycheck Protection Program Loans on our Condensed Consolidated Balance Sheet as of March 31, 2022, net of the short-term portion of $18,210. The issuing bank determined that this loan qualifies for loan forgiveness, however the Company is awaiting final approval from the Small Business Administration.

NOTE 15 – STOCKHOLDERS’ EQUITY

Preferred Stock

The Company is authorized to issue 10,000,000 shares of Preferred Stock, $0.001 par value. As of March 31, 2022, and September 30, 2021, there were 2,029,753 and 1,935,151 shares issued and outstanding, respectively.

Series 1 Preferred Stock

During the six months ended March 31, 2022, 94,602 shares of Series 1 Preferred Stock were issued to pay dividends to holders of Series 1 Preferred Stock.

As of March 31, 2022, and September 30, 2021, there were 1,979,753 and 1,885,151 shares of Series 1 Preferred Stock issued and outstanding, respectively.

Series C Preferred Stock

On October 3, 2019, pursuant to Article IV of our Articles of Incorporation, our Board of Directors voted to designate a class of preferred stock entitled Series C Preferred Stock, consisting of up to one hundred thousand (100,000) shares, par value $0.001. Under the Certificate of Designation, holders of Series C Preferred Stock are entitled to the number of votes equal to the result of (i) the total number of shares of Common Stock outstanding at the time of such vote multiplied by 10.01, and divided by (ii) the total number of shares of Series C Preferred Stock outstanding at the time of such vote, at each meeting of our shareholders with respect to any and all matters presented to our shareholders for their action or consideration, including the election of directors.

As of March 31, 2022, and September 30, 2021, there were 50,000 shares of Series C Preferred Stock issued and outstanding.

19

Common Stock

The Company is authorized to issue 50,000,000 shares of common stock, $0.001 par value. As of March 31, 2022, there were 24,673,210 shares issued and outstanding and at September 30, 2021, there were 20,782,194 shares issued and outstanding.

During the six months ended March 31, 2022, 2,891,016 shares of the Company’s common stock have been issued to satisfy $2,112,500 of notes payable, $353,978 in accrued interest, and $821,593 of excess value of shares issued recorded as interest expense. An additional 1,000,000 shares were issued in connection with a note payable issued on February 22, 2022.

NOTE 16 – SHARE-BASED COMPENSATION

For the six months ended March 31, 2022, and 2021, the Company recognized $72,417 and $65,317 of share-based compensation expense on its outstanding options, respectively. As of March 31, 2022, $174,318 of unrecognized share-based compensation expense is expected to be recognized over a period of four years. Future compensation amounts will be adjusted for any change in estimated forfeitures.

NOTE 17 – COMMITMENTS AND CONTINGENCIES

The Company has its corporate headquarters in New York City with a 12-month lease of 2,500 square feet of office space at a rate of $10,000 per month.

The Company’s IS segment owns approximately 25,000 square feet of warehouse space in Manchester, PA and approximately 43,000 square feet of office and warehouse space in York, PA. The IS segment also leases approximately 15,500 square feet of warehouse space in Emigsville, PA from a third party in a three-year lease at a monthly rent of $4,555 expiring on August 31, 2022.

The Company’s AT segment leases (i) approximately 6,700 square feet of office and warehouse space in Pune, India from a third party in an five year lease at a monthly rent of $6,453 (INR456,972) expiring on February 28, 2024, (ii) approximately 30,000 square feet of office and warehouse space in Hauppauge, New York from a third party in a seven-year lease at a monthly rent of $28,719 expiring on March 31, 2027, and (iii) approximately 9,400 square feet of office and warehouse space in Hampshire, England in a fifteen-year lease with at a monthly rent of $7,329 (£5,771) which expires on March 24, 2031 and contains provisions to terminate in 2026.

NOTE 18 – SUBSEQUENT EVENTS

Cemtrex has evaluated subsequent events up to the date the condensed consolidated financial statements were issued. Cemtrex concluded that the following subsequent events have occurred and require recognition or disclosure in the condensed consolidated financial statements.

In April and May of 2022, the Company issued an aggregate of 1,590,086 shares of common stock to settle $600,000 of notes payable, and $105,053 of excess value of shares issued recorded as interest expense.

On April 7, 2022, 99,369 shares of Series 1 Preferred Stock were issued to pay dividends to holders of Series 1 Preferred Stock. The holders of the Series 1 Preferred Stock are entitled to receive dividends at the rate of 10% annually, based on the $10.00 per share Preference Amount, payable semiannually.

20

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

Except for historical information contained in this report, the matters discussed are forward-looking statements that involve risks and uncertainties. When used in this report, words such as “anticipates”, “believes”, “could”, “estimates”, “expects”, “may”, “plans”, “potential” and “intends” and similar expressions, as they relate to the Company or its management, identify forward-looking statements. Our operations involve risks and uncertainties, many of which are outside our control, and any one of which, or a combination of which, could materially affect our results of operations and whether the forward-looking statements ultimately prove to be correct. We have based these forward-looking statements largely on our current expectations and projections about future events and trends that we believe may affect our financial condition, results of operations, business strategy, short-term and long-term business operations and objectives, and financial needs. Such forward-looking statements are based on the beliefs of the Company’s management, as well as assumptions made by and information currently available to the Company’s management. Among the factors that could cause actual results to differ materially are the following: the effect of business and economic conditions; the impact of competitive products and their pricing; unexpected manufacturing or supplier problems; the Company’s ability to maintain sufficient credit arrangements; changes in governmental standards by which our environmental control products are evaluated and the risk factors reported from time to time in the Company’s SEC reports, including its recent report on Form 10-K. The Company undertakes no obligation to update forward-looking statements as a result of future events or developments.

General Overview

Cemtrex was incorporated in 1998, in the state of Delaware and has evolved through strategic acquisitions and internal growth into a leading multi-industry technology company. The Company has expanded in a wide range of sectors, including smart technologies, virtual and augmented realities, industrial solutions, and intelligent security systems. Unless the context requires otherwise, all references to “we”, “our”, “us”, “Company”, “registrant”, “Cemtrex” or “management” refer to Cemtrex, Inc. and its subsidiaries.

The Company has two business segments, consisting of (i) Advanced Technologies (AT) and (ii) Industrial Services (IS).

Advanced Technologies (AT)

Cemtrex’s Advanced Technologies segment operates several brands that deliver cutting-edge software and hardware technologies:

| - | Vicon Industries – Vicon Industries, a majority owned subsidiary, provides end-to-end video security solutions to meet the toughest corporate, industrial and governmental security challenges. Vicon’s products include browser-based video monitoring systems and analytics-based recognition systems, cameras, servers, and access control systems for every aspect of security and surveillance in industrial and commercial facilities, federal prisons, hospitals, universities, schools, and federal and state government offices. Vicon provides cutting edge, mission critical security and video surveillance solutions utilizing Artificial Intelligence (AI) based data algorithms.
| - | SmartDesk – SmartDesk is focused on reinventing the workspace through developing state-of-the-art, modern, fully integrated, workplace solutions.
| - | Cemtrex XR (“CXR”) – CXR is focused on realizing the potential of the metaverse. CXR delivers Virtual Reality (VR) and Augmented Reality (AR) solutions that provide higher productivity, progressive design and impactful experiences for consumer products, and various commercial and industrial applications. The Company is in the process of developing virtual reality applications for commercialization in the metaverse over the next couple years. CXR also invests in emerging startups focused on building best in class solutions for the metaverse.
| - | Virtual Driver Interactive (“VDI”) – VDI provides innovative driver training simulation solutions for effective and engaging learning for all ages and skills.
| - | Bravo Strong – Bravo Strong is a gaming and content studio working to building games and experiences for the metaverse.
| - | good tech (formerly Cemtrex Labs) – good tech provides mobile, web, and enterprise software application development services for startups to large enterprises.

21

Industrial Services (IS)

Cemtrex’s IS segment operates through a brand, Advanced Industrial Services (“AIS”), that offers single-source expertise and services for rigging, millwrighting, in plant maintenance, equipment erection, relocation, and disassembly to diversified customers. We install high precision equipment in a wide variety of industrial markets like automotive, printing & graphics, industrial automation, packaging, and chemicals among others. We are a leading provider of reliability-driven maintenance and contracting solutions for the machinery, packaging, printing, chemical, and other manufacturing markets. The focus is on customers seeking to achieve greater asset utilization and reliability to cut costs and increase production from existing assets, including small projects, sustaining capital, turnarounds, maintenance, specialty welding services, and high-quality scaffolding.

Significant Accounting Policies and Estimates

Our discussion and analysis of our financial condition and results of operations are based upon the accompanying unaudited condensed consolidated financial statements, which have been prepared in accordance with accounting principles generally accepted in the United States (“U.S. GAAP”). The preparation of financial statements in conformity with U.S. GAAP requires management to make judgments, estimates and assumptions that affect the reported amounts of assets, liabilities, revenue, expenses, and the related disclosures at the date of the financial statements and during the reporting period. Although these estimates are based on our knowledge of current events, our actual amounts and results could differ from those estimates. The estimates made are based on historical factors, current circumstances, and the experience and judgment of our management, who continually evaluate the judgments, estimates and assumptions and may employ outside experts to assist in the evaluations.

Certain of our accounting policies are deemed “significant”, as they are both most important to the financial statement presentation and require management’s most difficult, subjective or complex judgments as a result of the need to make estimates about the effect of matters that are inherently uncertain. For a discussion of our significant accounting policies, see “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in our Annual Report on Form 10-K for the year ended September 30, 2021.

Results of Operations – For the three months ending March 31, 2022, and 2021

Total revenue for the three months ended March 31, 2022, and 2021 was $12,728,215 and $9,260,385, respectively, an increase of $3,467,830, or 37%. Loss from operations for the three months ended March 31, 2022, was $3,819,337 compared to $1,962,598 for the three months ended March 31, 2021, an increase on the loss of $1,856,739, or 95%. Total revenue for the quarter increased, as compared to total revenue in the same period last year, due to shutdowns and limited operations of businesses due to the COVID-19 crisis during the same period last year. Loss from operations increased due to increased expenses related to personnel costs, travel, and research and development costs.

Revenues

Our Advanced Technologies segment revenues for the three months ended March 31, 2022, increased by $2,234,893 or 41% to $7,722,307 from $5,487,414 for the three months ended March 31, 2021. This increase is mainly due to an improvement in economic climate from the impact of the COVID-19 crisis during the same period last year.

Our Industrial Services segment revenues for the three months ended March 31, 2022, increased by $1,232,937 or 33%, to $5,005,908 from $3,772,971 for the three months ended March 31, 2021. This increase is mainly due to an improvement in economic climate from the impact of the COVID-19 crisis during the same period last year.

Gross Profit

Gross Profit for the three months ended March 31, 2022, was $4,052,611 or 32% of revenues as compared to gross profit of $3,928,884 or 42% of revenues for the three months ended March 31, 2021. Gross profit as a percentage of revenues decreased in the three months ended March 31, 2022, compared to the three months ended March 31, 2021, due to increased cost of revenues as a result of supply chain difficulties and increased transportation costs for goods. The Company’s gross profit margins vary from product to product and from customer to customer.

22

General and Administrative Expenses

General and administrative expenses for the three months ended March 31, 2022, increased $1,507,248 or 29% to $6,757,233 from $5,249,985 for the three months ended March 31, 2021. General and administrative expenses as a percentage of revenues was 53% and 57% of revenues for the three-month periods ended March 31, 2022, and 2021, respectively. The increase in general and administrative expenses is the result of increased personnel, travel, depreciation and amortization, and insurance expenses.

Research and Development Expenses

Research and Development expenses for the three months ended March 31, 2022, was $1,114,715 compared to $641,497 for the three months ended March 31, 2021. Research and Development expenses are primarily related to the Advanced Technologies Segment’s development of proprietary technology and further developments of the SmartDesk and Artificial Intelligence (AI) and next generation solutions associated with security and surveillance systems software.

Other Income/(Expense)

Other income/(expense) for the second quarter of fiscal 2022, was $(982,586) as compared to $4,505,033 for the second quarter of fiscal 2021. Other income/(expense) for the three months ended March 31, 2022, included the issuance of common stock in connection with a note payable of $700,400.

Provision for Income Taxes

During the second quarter of fiscal 2022, the Company did not record an income tax provision compared to $98,477 for the second quarter of fiscal 2021. The provision for income tax is based upon the projected income tax from the Company’s various U.S. and international subsidiaries that are subject to their respective income tax jurisdictions and the Company’s projected ability to utilize net loss carryforwards.

Net income/(loss) attributable to Cemtrex, Inc. shareholders

The Company had a net loss attributable to Cemtrex, Inc. shareholders of $4,721,247, or 37% of revenues, for the three-month period ended March 31, 2022, as compared to net income attributable to Cemtrex, Inc. shareholders of $2,454,132 or 27% of revenues, for the three months ended March 31, 2021. Net loss attributable to Cemtrex, Inc. shareholders increased in the first quarter as compared to the same period last year was primarily due to costs of revenues, operating, and other expenses mentioned above.

Results of Operations – For the six months ending March 31, 2022, and 2021

Total revenue for the six months ended March 31, 2022, and 2021 was $23,400,704 and $18,096,461 respectively, an increase of $5,304,243, or 29%. Loss from operations for the six months ended March 31, 2022, was $7,873,860 compared to $4,008,549 for the six months ended March 31, 2021, an increase on the loss of $3,865,311, or 96%. Total revenue for the period increased, as compared to total revenue in the same period last year, due to shutdowns and limited operations of businesses due to the COVID-19 crisis during the same period last year. Loss from operations increased due to increased expenses related to personnel costs, depreciation and amortization, insurance, travel, and research and development costs.

Revenues

Our Advanced Technologies segment revenues for the six months ended March 31, 2022, increased by $3,180,541 or 31% to $13,340,824 from $10,160,283 for the six months ended March 31, 2021. This increase is mainly due to an improvement in economic climate from the impact of the COVID-19 crisis during the same period last year.

23

Our Industrial Services segment revenues for the six months ended March 31, 2022, increased by $2,123,702 or 27%, to $10,059,880 from $7,936,178 for the six months ended March 31, 2021. This increase is mainly due to an improvement in economic climate from the impact of the COVID-19 crisis during the same period last year.

Gross Profit

Gross Profit for the six months ended March 31, 2022, was $7,921,805 or 34% of revenues as compared to gross profit of $7,934,354 or 44% of revenues for the six months ended March 31, 2021. Gross profit decreased in the six months ended March 31, 2022, compared to the six months ended March 31, 2021, due to increased cost of revenues as a result of supply chain difficulties and increased transportation costs for goods. The Company’s gross profit margins vary from product to product and from customer to customer.

General and Administrative Expenses

General and administrative expenses for the six months ended March 31, 2022, increased $2,702,056 or 25% to $13,369,237 from $10,667,181 for the six months ended March 31, 2021. General and administrative expenses as a percentage of revenues was 57% and 59% of revenues for the six-month periods ended March 31, 2022, and 2021, respectively. The increase in general and administrative expenses is the result of increased personnel, travel, depreciation and amortization, and insurance expenses.

Research and Development Expenses

Research and Development expenses for the six months ended March 31, 2022, was $2,426,428 compared to $1,275,722 for the six months ended March 31, 2021. Research and Development expenses are primarily related to the Advanced Technologies Segment’s development of proprietary technology and further developments of the SmartDesk and Artificial Intelligence (AI) and next generation solutions associated with security and surveillance systems software.

Other Income/(Expense)

Other income/(expense) for the first and second quarters of fiscal 2022, was $(1,457,886) as compared to $4,847,080 for the first and second quarters of fiscal year 2021. Other income/(expense) for the six months ended March 31, 2022, included the gain on the forgiveness of our PPP loans of $971,500 and the issuance of common stock in connection with a note payable of $700,400.

Provision for Income Taxes

During the first and second quarters of fiscal year 2022, the Company did not record an income tax provision compared to $127,431 for the first and second quarters of fiscal year 2021. The provision for income tax is based upon the projected income tax from the Company’s various U.S. and international subsidiaries that are subject to their respective income tax jurisdictions and the Company’s projected ability to utilize net loss carryforwards.

Net income/(loss) attributable to Cemtrex, Inc. shareholders

The Company had a net loss attributable to Cemtrex, Inc. shareholders of $9,199,198, or 39% of revenues, for the six-month period ended March 31, 2022, as compared to net income attributable to Cemtrex, Inc. shareholders of $761,521 or 4% of revenues, for the six months ended March 31, 2021. Net loss attributable to Cemtrex, Inc. shareholders increased in the first and second quarters of fiscal year 2022 as compared to the same period last year was primarily due to costs of revenues and operating expenses mentioned above.

Effects of Inflation

The Company’s business and operations have not been materially affected by inflation during the periods for which financial information is presented.

24

Liquidity and Capital Resources

Working capital was $7,604,437 at March 31, 2022, compared to $15,088,892 at September 30, 2021. This includes cash and equivalents and restricted cash of $10,630,229 at March 31, 2022, and $17,186,323 at September 30, 2021. The decrease in working capital was primarily due to the Company’s use of cash to build inventory and a shift of liabilities to short-term during the first two quarters of fiscal year 2022.

Accounts receivable decreased $1,805,328 or 23% to $6,005,568 at March 31, 2022, from $7,810,896 at September 30, 2021. The decrease in accounts receivable is attributable to increased collection efforts to keep our accounts receivable from going past due.

Inventories increased $1,409,367 or 25% to $7,066,654 at March 31, 2022, from $5,657,287 at September 30, 2021. The increase in inventories is attributable to the purchase of inventories for new products the Company plans to ship in the future and to build up stock inventory to account for supply chain issues.

Cash used by operating activities for the six months ended March 31, 2022 and 2021 was $7,235,840 and $2,865,654 respectively. The decrease in operating cash flows was primarily due to purchases on inventory and payment of accounts payable and accrued expenses.

Cash used by investment activities for the six months ended March 31, 2022 and 2021 was $5,654,515 and $110,129, respectively. Investing activities for the first and second quarters of fiscal year 2022 were driven by the Company’s purchase of fixed assets, the additional investment in Masterpiece VR, and marketable securities.

Cash provided by financing activities for the six months ended March 31, 2022 and 2021 was $6,484,337 and $754,748, respectively. Financing activities were primarily driven by proceeds from the note payable issued in February of 2022.

We believe that our cash on hand and cash generated by operations is sufficient to meet the capital demands of our current operations for fiscal year 2022 (ending September 30, 2022). Any major increases in sales, particularly in new products, may require substantial capital investment. Failure to obtain sufficient capital could materially adversely impact our growth potential.

Overall, there is no guarantee that cash flow from our existing or future operations and any external capital that we may be able to raise will be sufficient to meet our expansion goals and working capital needs.

25

Item 4. Controls and Procedures

Evaluation of Disclosure Controls and Procedures

Disclosure controls and procedures reporting as promulgated under the Exchange Act is defined as controls and procedures that are designed to ensure that information required to be disclosed by us in the reports that we file or submit under the Exchange Act are recorded, processed, summarized and reported within the time periods specified in the SEC rules and forms. Disclosure controls and procedures include without limitation, controls and procedures designed to ensure that information required to be disclosed by us in the reports that we file or submit under the Exchange Act is accumulated and communicated to our management, including our Chief Executive Officer (“CEO”) and Chief Financial Officer (“CFO”), or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure.

Our CEO and our CFO have evaluated the effectiveness of the design and operation of our disclosure controls and procedures as of March 31, 2022. Our disclosure controls and procedures were not effective and Based on their evaluation, our management has concluded that as of March 31, 2022, our disclosure controls and procedures were not effective and there is a material weakness in our internal control over financial reporting. The material weakness relates to the Company lacking sufficient accounting personnel. The shortage of accounting personal resulted in the Company lacking entity level controls around the review of period-end reporting processes, accounting policies and public disclosures. Additionally, the Company’s current processes and systems do not provide for necessary, timely reconciliation of certain accounts and sufficient consideration regarding recoverability of certain assets. This deficiency is common in small companies, similar to us, with limited personnel.

Notwithstanding the conclusion by our Chief Executive Officer and Chief Financial Officer that our disclosure controls and procedures as of March 31, 2022, were not effective, and notwithstanding the material weakness in our internal control over financial reporting described below, management believes that the unaudited condensed financial statements and related financial information included in this Quarterly Report fairly present in all material respects our financial condition, results of operations and cash flows as of the dates presented, and for the periods ended on such dates, in conformity with GAAP.

In order to mitigate the material weakness, the Board of Directors has assigned a priority to the short-term and long-term improvement of our internal control over financial reporting. Our Board of Directors will work with management to continuously review controls and procedures to identified deficiencies and implement remediation within our internal controls over financial reporting and our disclosure controls and procedures.

Changes in Internal Control Over Financial Reporting

While there was no change in the Company’s internal control over financial reporting during the Company’s last fiscal quarter that has materially affected, or is reasonably likely to materially affect, the Company’s internal control over financial reporting, the Company is taking steps to improve its internal controls by obtaining additional accounting personnel.

Limitations on the Effectiveness of Controls

Our management, including our CEO and CFO, does not expect that our disclosure controls and procedures or our internal controls will prevent all errors and all fraud. A control system, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met. Further, the design of a control system must reflect the fact that there are resource constraints, and the benefits of controls must be considered relative to their costs. Due to the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, within our company have been detected.

26

Part II Other Information

Item 1. Legal Proceedings.

NONE.

Item 1A. Risk Factors

See Risk Factors included in our Annual Report on Form 10-K for 2021.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.

During the six months ended March 31, 2022 the Company issued an aggregate of 2,891,016 shares of common stock to settle $2,112,500 of notes payable, $353,978 in accrued interest, and $821,593 of excess value of shares issued recorded as interest expense. Additionally, the Company issued another 1,000,000 shares in connection with the issuance of a note payable on February 22, 2022. The fair market value of the shares, $700,400 has been recorded as interest expense on the Company’s Condensed Consolidated Statement of Operations and Comprehensive Income/(Loss). Such shares were issued pursuant to the exemption contained under Section 4(a)(2) of the Securities Act of 1933, as amended.

27

Item 6. Exhibits

Exhibit No. |  | Description
2.2 |  | Stock Purchase Agreement regarding the stock of Advanced Industrial Services, Inc., AIS Leasing Company, AIS Graphic Services, Inc., and AIS Energy Services, LLC, Dated December 15, 2015. (8)
2.3 |  | Asset Purchase agreement between Periscope GmbH and ROB Centrex Assets UG, ROB Cemtrex Automotive GmbH, and ROB Cemtrex Logistics GmbH. (7)
3.1 |  | Certificate of Incorporation of the Company.(1)
3.2 |  | By Laws of the Company.(1)
3.3 |  | Certificate of Amendment of Certificate of Incorporation, dated September 29, 2006.(1)
3.4 |  | Certificate of Amendment of Certificate of Incorporation, dated March 30, 2007.(1)
3.5 |  | Certificate of Amendment of Certificate of Incorporation, dated May 16, 2007.(1)
3.6 |  | Certificate of Amendment of Certificate of Incorporation, dated August 21, 2007.(1)
3.7 |  | Certificate of Amendment of Certificate of Incorporation, dated April 3, 2015.(3)
3.8 |  | Certificate of Designation of the Series A Preferred Shares, dated September 8, 2009.(2)
3.9 |  | Certificate of Designation of the Series 1 Preferred Stock.(11)
3.10 |  | Certificate of Amendment of Certificate of Incorporation, dated September 7, 2017 (12)
3.11 |  | Certificate of Correction to the Certificate of Amendment to the Amended and Restated Certificate of Incorporation, as amended, of Cemtrex, Inc (6)
3.12 |  | Amended Certificate of Designation of the Series 1 Preferred Shares, dated March 30, 2020.(16)
3.13 |  | Certificate of Amendment of Certificate of Incorporation, dated July 29, 2020 (20)
3.14 |  | Certificate of Correction of Certificate of Incorporation, dated July 29, 2021, filed October 7, 2020 (9)
4.1 |  | Form of Subscription Rights Certificate. (10)
4.2 |  | Form of Series 1 Preferred Stock Certificate. (10)
4.3 |  | Form of Series 1 Warrant. (10)
4.4 |  | Form of Common Stock Purchase Warrant, dated March 22, 2019. (14)
10.1 |  | Amendment of the Term Loan Agreement between Vicon and NIL Funding, dated March 4, 2020.(17)
10.2 |  | Consulting Agreement, dated April 22, 2020 between Centrex, Inc. and Adtron, Inc. (5)
10.3 |  | Securities Purchase Agreement dated June 1, 2020 (18)
10.4 |  | Securities Purchase Agreement dated June 9, 2020 (19)
10.5 |  | Settlement Agreement and Release between Cemtrex, Inc. and Aron Govil dated February 26, 2021 (13)
10.6* |  | Securities Purchase Agreement dated February 22, 2022
10.7* |  | Amendment of the Term Loan Agreement between Vicon and NIL Funding, dated March 30, 2022.
14.1 |  | Corporate Code of Business Ethics.(4)
21.1* |  | Subsidiaries of the Registrant
31.1* |  | Certification of Chief Executive Officer as required by Rule 13a-14 or 15d-14 of the Exchange Act, as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
31.2* |  | Certification of Interim Chief Financial Officer and Principal Financial Officer as required by Rule 13a-14 or 15d-14 of the Exchange Act, as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
32.1* |  | Certification of Chief Executive Officer Pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act 0f of 2002.
32.2* |  | Certification of Interim Chief Financial Officer and Principal Financial Officer Pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act 0f of 2002.
101.INS* |  | Inline XBRL Instance Document
101.SCH* |  | Inline XBRL Taxonomy Extension Schema
101.CAL* |  | Inline XBRL Taxonomy Extension Calculation Linkbase
101.DEF* |  | Inline XBRL Taxonomy Extension Definition Linkbase
101.LAB* |  | Inline XBRL Taxonomy Extension Label Linkbase
101.PRE* |  | Inline XBRL Taxonomy Extension Presentation Linkbase
104 |  | Cover Page Interactive Data File (embedded within the Inline XBRL document)

* | Filed herewith
1 | Incorporated by reference from Form 10-12G filed on May 22, 2008.
2 | Incorporated by reference from Form 8-K filed on September 10, 2009.
3 | Incorporated by reference from Form 8-K filed on August 22, 2016.
4 | Incorporated by reference from Form 8-K filed on July 1, 2016.
5 | Incorporated by reference from Form S-8 filed on May 1, 20120
6 | Incorporated by reference from Form 8-K filed on June 12, 2019.
7 | Incorporated by reference from Form 8-K/A filed on November 24, 2017.
8 | Incorporated by reference from Form 8-K/A filed on September 26, 2016.
9 | Incorporated by reference from Form 10-Q filed on May 28, 2021.
10 | Incorporated by reference from Form S-1 filed on August 29, 2016 and as amended on November 4, 2016, November 23, 2016, and December 7, 2016.

28

11 | Incorporated by reference from Form 8-K filed on January 24, 2017.
12 | Incorporated by reference from Form 8-K filed on September 8, 2017.
13 | Incorporated by reference from Form 8-K filed on February 26, 2021.
14 | Incorporated by reference from Form 8-K filed on March 22, 2019.
15 | Intentionally left blank
16 | Incorporated by reference from Form 8-K filed on April 1, 2020.
17 | Incorporated by reference from Form 8-K filed on March 9, 2020.
18 | Incorporated by reference from Form 8-K filed on June 4, 2020.
19 | Incorporated by reference from Form 8-K filed on June 12, 2020.
20 | Incorporated by reference from Form 10-K filed on January 5, 2021.

29

Signatures

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

| Cemtrex, Inc.
Dated: May 16, 2022 | By: | /s/Saagar Govil
|  | Saagar Govil
|  | Chief Executive Officer
Dated: May 16, 2022 |  | /s/Paul J. Wyckoff
|  | Paul J. Wyckoff
|  | Interim Chief Financial Officer and Principal Financial Officer

30